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Inflammatory cellular signaling underlies diseases of the surface of the eye 
such as keratoconjunctivitis sicca, pterygium, allergic conjunctivitis as well as 
scarring  from  infections. Conventional treatments for inflammation have relied 
principally on glucocorticoids which are well known to produce adverse events such 
as glaucoma and cataract. To develop more specific therapies, the origins and 
consequences of inflammatory signaling must be understood for ocular surface cells. 
One gene group ,the  transglutaminases (TGM), has emerged as  a class of enzymes 
that cross-link cellular substrates to mediate critical immune-inflammatory signaling. 
Some studies implicate TGM-2 in allergic conjunctivitis, corneal epithelial 
wound healing and pterygium, and TGM-1 in dry eye and cicatricial 
keratoconjunctivitis. Despite these studies, little is known about TGM’s role on the 
ocular surface inflammatory responses and particularly in more chronic conditions. 
The experiments in this thesis were therefore aimed to elucidate the roles of TGM in 
human corneal epithelial cells. 
A global transcript profiling study (human exon array) in cultured human 
corneal epithelial cells (HCEC-T) showed that over-expression of TGM-2 up-
regulated the late cornified envelope protein 2B, keratin associated protein 9-3 and 
microRNA hsa-mir-124a-3. In addition, over-expression was associated with the 
alternate splicing of transcripts of interleukin-17F and human beta-defensin 119. 
Ultraviolet (UVB) stimulation of HCEC-T activated apoptosis. Morphological 
changes in cytoplasm and nuclei, and evidence of DNA fragmentation were observed. 
UVB also stimulated an increase in TGM-1 and TGM-2 transcript, protein and 
transamidase activity. UVB-induced apoptosis was mediated in part by TGM-2 
through the activation of caspase-3. In the absence of UVB, caspase activation was 
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detected after intracellular delivery of exogenous TGM-2, or after over-expression of 
human TGM-2 via plasmid transfection. The TGM-2 associated caspase-3 was active, 
and this activity was suppressed with a pan-caspase inhibitor. Western blot analysis of 
mitochondrial extracts revealed TGM-2, which had not been previously documented.  
The cornified envelope proteins, natural TGM substrates, were investigated in 
the human corneal epithelium as well as in cultured primary corneal epithelial cells. 
By cross-linking these substrates, TGM mediated the stratification and formation of 
barrier in the epithelium. The transcript levels of members of small proline-rich 
proteins, members of this cornified envelope proteins, were decreased after UVB but 
this decrease was partially inhibited by monodansyl cadaverine (MDC), a TGM 
inhibitor. Transepithelial electrical resistance studies in HCEC-T, validated by studies 
with dextran-Alexa 488 conjugates, showed that UVB reduced the barrier function of 
HCEC-T, which was partially suppressible by MDC. 
Other studies in HCE-T showed that TGM-2 was involved in the UVB-
induced activation of the nuclear-factor kappa (NF-κ)B pathway, as well as the Toll-
like receptor 1/2 stimulated NF-κB activity. Over-expression of TGM-2 in HCE-T 
was also associated with up-regulation of phospholipase (PL)D3 transcripts. PLD3 
belongs to a class of enzymes involved in cell motility and inflammation.  
In conclusion, though additional details of TGM-2 signaling in the corneal 
epithelium remains to be elucidated, these studies have established that TGM 
pathways are critical to the modulation of cell stress, and that TGM-related signaling 
pathways may contain useful therapeutic targets to combat ocular surface diseases.  
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CHAPTER I. INTRODUCTION 
1.1 Ocular surface disease  
1.1.1 Definition of ocular surface disease 
Ocular surface disease refers to diseases of the conjunctiva and cornea. This 
encompasses the exposed part of the eye bathed by the tear film. Although the 
lacrimal apparatus is also considered by many to be part of the ocular surface, it is not 
included in the scope of this thesis. 
1.1.2 Importance of ocular surface disease 
Ocular surface inflammation is an important component of common diseases 
like dry eye, pterygium, allergic conjunctivitis and infections, and also less common 
but devastating diseases like Steven Johnson syndrome and other forms of cicatrizing 
conjunctivitis. These diseases not only cause a lot of morbidity such as redness and 
pain but also permanent loss of sight, reducing the quality of life (Dalzell 2003). The 
more common conditions are a definite burden to society in terms of direct health-
related spending and indirect costs such as time off work (Pitt et al 2004). It has been 
shown that the long term efforts to develop an effective medical therapy for ocular 
surface inflammation is a justifiable endeavor, despite the risks involved (Novack 
2002). 
1.1.3 Current treatment of ocular surface disease 
For the last 40 years, the mainstay of treatment for ocular inflammation is 
some form of glucocorticoid therapy (Barnes 2006). This form of treatment can incur 
serious adverse effects such as glaucoma and cataracts, which are by themselves sight 
threatening conditions. The reason for the unwanted effects can be attributed to the 
lack of specificity of these drugs at the cellular and molecular level (Barnes 2006). It 
is now generally understood in areas such as oncology and inflammatory diseases that 
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effective treatment will require combinatorial targeting of various signaling pathways 
(Albert et al 2000). Such treatment, if available, will likely be more effective and 
safer than broad action immunosuppressive therapy such as steroidal treatment. This 
type of approach however, has not yet been implemented in routine clinical practice 
in ocular surface diseases.  
It is estimated that up to 8000 molecules within cells can be potentially 
targeted by drugs, out of which 5000 can be targeted by small molecules (Butcher 
2003). The paradigm of finding a single, specific agent with minimal adverse events 
is changing to that of multiple intervention at related or compensatory pathways to 
achieve greater therapeutic effect and still avoid the critical pathways for the normal 
cell functioning (Butcher 2005). This increases the importance of understanding 
molecular processes of diseases, especially in the tissue specific context (Pflugfelder 
et al 2005). This is why the experiments described in this thesis are so vitally 
important. 
1.2 Transglutaminase 
1.2.1 Transglutaminase in ocular surface disease  
Trans-glutaminases (TGM) play an important role in ocular surface diseases 
such as pterygium (Kim et al 1998), allergic conjunctivitis (Sohn et al 2003) and dry 
eye (Toshino et al 2005). They are involved in important biological processes such as 
ocular surface wound healing (Zhang et al 2004), differentiation of central nervous 
system stem cells (Eitan et al 1994), immune function (Mehta et al 1986), and 
behavioral properties of tumors (Mehta 1994, Chen et al 1999, Mangala et al 2005a, 
Mangala et al 2005b). Recently, the use of TGM inhibitors in the treatment of allergic 
conjunctivitis in an animal model (Sohn et al 2003) supported its role in inflammatory 
signaling (Cordella-Miele et al 1990, Miele 2003, Falasca et al 2005). The scarring in 
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conjunctiva post glaucoma surgery, a major cause of surgical failure, is TGM-2 
mediated (Stephens et al 2004, Priglinger et al 2006). The functional recovery of 
severed optic nerve in rats after injection of TGM-2 attests to the therapeutic potential 
of this enzyme (Eitan et al 1994). In addition, the prognostication of cancers based on 
TGM-2 expression (Mehta et al 2004) and the loss of viability of tumor cells after 
administration of TGM-2 interfering RNA suggests a wider role for TGM-2 based 
clinical application (Herman et al 2006). The viability and general health of TGM-2 
knock out mice (Bernassola et al 2002) suggests that therapeutic reduction in TGM-2 
function may not be adversely toxic. TGM-2 is not only present in the corneal 
epithelium (Raghunath et al 1999), but also present in cultured corneal epithelial cells 
(Tong et al 2005).  
1.2.2 Transglutaminase functions in biology 
TGM-2 is the most well known member in a conserved family of multi-
functional enzymes (Mehta 2005) that can not only serve as a transamidase (Lee et al 
1993), but also as a GTPase (Mhaouty-Kodja 2004), a kinase (Mishra et al 2004), or 
even a protein disulphide isomerase (Hasegawa et al 2003).  
In a transamidase reaction, typically the glutamine residue of a peptide is 
cross-linked covalently with the lysine residue of another peptide or the same peptide. 
Interference with one aspect of the enzyme may not necessarily affect other biological 
functions mediated by this enzyme. This is possible because different domains of the 
protein mediate these functions, a fact which is supported by the known 
crystallography derived structure of the TGM-2 protein (Liu et al 2002). For example, 
stabilization of apoptotic cells may be mediated by GTPase function (Nanda et al 
2001), rather than the transamidation. In physiological conditions, the GTPase 
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function of TGM-2 may be more important than that of the transamidase function 
(Rodolfo et al 2004). 
The recent surge in interest in TGMs is related to their roles in cancer 
metastasis (Mangala et al 2007) and inhibition of autophagy (Akar et al 2007, Ozpolat 
et al 2007). TGM-2 can affect inflammation in many ways. First, it can cross-link and 
activate phospholipase A2, which produce downstream pro-inflammatory mediators 
(Cordella-Miele et al 1990). Second, it can affect phagocytosis and endocytosis 
(Chaldakov 1990, Katoh et al 1994, Choi et al 2005) including phagocytosis of dead 
cell material (Falasca et al 2005). TGM-2 may also up-regulate immunosuppressive 
growth factors such as TGF-β (Falasca et al 2005). 
1.3 Ultraviolet radiation in the ocular surface 
Ultraviolet radiation is an important stimulus responsible for stress signaling 
in living cells (Kulms et al 2002a, Kulms et al 2002b) and tissues (Clydesdale et al 
2001). In ocular pathology, it is involved in conditions ranging from pterygium, 
photokeratitis, climatic droplet keratopathy, cataracts and photic maculopathy. In 
ocular surface cells, it has been implicated in processes such as expression of mucin 
(Corrales et al 2003) and proto-oncogenes (Wickert et al 1999), as well as activation 
of caspases (Shimmura et al 2004) and secretion of cytokines. (Kennedy et al 1997) 
UVB is an excellent model for studying TGM because UVB is known to trigger TGM 
activity (Shin et al 2004), although the extent of this has not been evaluated in ocular 
surface cells. 
1.4 Unanswered questions 
To evaluate the role of TGM-2 in a real ocular surface disease, a global gene 
expression study was undertaken in pterygium, a relatively common disease with 
unknown etiology (Chapter III). To answer the question: “What genes are regulated 
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by TGM-2?” A microarray study of TGM-2 over-expression in human corneal 
epithelial cells was performed (Chapter III). To address the role of TGM in the UVB-
induced apoptosis, experiments on cultured human corneal epithelial cells were 
conducted and described in Chapter IV. Chapter V describes the possible roles of 
TGM-2 in other signaling pathways. For example, the role of TGM-2 in the activation 
of nuclear factor-kappa (NF-κ)B, a transcription factor known to regulate production 
of inflammatory cytokines in diseases like dry eye. To address the role of TGM in the 
UVB-induced regulation of cornified envelope proteins, a series of experiments was 
executed (Chapter V). Cornified envelope proteins are not only crucial for 
maintaining the integrity of the corneal epithelial barrier and hence corneal 
transparency, but are also involved in wound healing and response to dessication. 
Chapter V also addresses the phospholipase (PL) D family of enzymes. These 
enzymes are important because they serve to produce pro-inflammatory lipid 
molecules which can be secreted and subsequently behave as first messengers, which 
have the potential to sustain ongoing inflammation. The relationship between TGM-2 
over-expression and PLD transcripts was also reported in Chapter V. In this thesis I 
demonstrated that TGM function, and to some extent, TGM-2 transcript and protein 
increase after UVB stimulation (Tong et al 2005), and these increases modulate the 
UVB-stress response of cornified envelope genes in corneal epithelial cells (Tong et 
al 2006) as well as the stress-induced decrease in corneal epithelial barrier function 
(Tong et al 2005). 
1.5 Specific aims 
The specific aims in this study were: 
1. To evaluate the role of transglutaminase (TGM)-2 in global gene 
expression in pterygium and human corneal epithelial cells, 
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2. understand the role of TGM-2 in corneal epithelial cell death, and 
3. investigate the role of TGM in signaling pathways relevant to 
inflammation-related ocular surface diseases.
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CHAPTER II. MATERIALS AND METHODS 
2.1 Cells and Tissues  
This thesis involves experimentation with various human cells: primary cornea 
epithelial cells, a corneal epithelial cell line (HCEC-T), as well as corneal derived 
fibroblasts. Tissues used included human conjunctiva, limbal and corneal tissue, as 
well as pterygial tissue removed from patients during pterygium surgery. All 
procedures adhered to the Tenets of the Declaration of Helsinki on human research. 
Details of the origin, culturing and passaging of these cells, as well as the handling of 
the human tissues have been provided in Appendix A1 and A2. 
Pterygium tissue was available through the Pterygium Aetiology and 
Conjunctival Evaluation (PACE) study, which was a clinical study approved by the 
Institutional Review Board of Singapre National Eye Center. Informed consent was 
obtained from all participants. In the microarray study on pterygium, primary 
pterygium tissues from 9 patients were used. At the time of surgery, a 1X1 mm piece 
of uninvolved conjunctiva from the superior bulbar conjunctiva was procured from 
each patient. However, such a small piece of tissue contained insufficient RNA for 
microarray experiments. Therefore, 16 patient’s ‘un-involved conjunctiva’ tissues 
were pooled into 4 control samples for this experiment. Only patients from 40-60 
years old were included. 
2.2 Transglutaminase plasmids 
DNA expression vectors or plasmids were used for various purposes in this 
thesis. For example, cDNA plasmids for the expression of wild-type and mutant 
TGM-2 were used (Figure 1). The procedure for transfection is provided in Appendix 
A4. In addition, plasmids have been used for various other purposes, for example, the 
pSG5 vector without insert and a humanised green fluorescent protein expression 
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plasmid have been used as transfection controls. To determine whether transamidation 
is a requirement for signal transduction, one can comparing the effects of the wild 
type with the mutant TGM-2. Since the transamidation function of the enzyme is 
critically dependent on the presence of cysteine 277 of TGM-2 (which is required to 
form an intermediate with the substrate during the catalytic process), a mutant TGM-2 
with replacement of cysteine 277 by serine has been constructed which is defective in 
transamidation (Lee et al 1993). Since this only results in the replacement of a sulfur 
atom in the wild type protein by an oxygen, the structure of the protein remains 
largely intact, and so is the GTPase function. Increase in TGM-2 transcript and 
protein expression using these plasmids (Figure 1) could be verified using techniques 
described in the Appendix A4.  
The silencing of TGM-2 using synthetic siRNA has been described in 
Appendix A4. This process can typically knock down TGM-2 transcript levels to ¼ - 
1/3 of the control levels (Figure 1). The silencing of TGM-2 using the pSM2 plasmid, 
which expressed a short hairpin RNA targeting TGM-2 transcripts was also used. This 
process is efficient in the human corneal epithelial cell line HCE-T using two 
different methods of transfection (Figure 1). 
The pSEAP plasmid has been used as a reporter for NF-κB activity (Chapter 
V) and the pSEAP control and basic plasmids as experimental controls. The source, 
propagation of these plasmids, as well as transfection procedures have been described 
in the Appendix A4. Appendix A13 also describes the basis of the pSEAP assay.   
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Figure 1. Over-expression and silencing of TGM-2. A. Construct of pSG5 Tgase and pSG5 Tgase 
M and the pSG5 vector map. B. Real time PCR. Up-regulation of TGM-2 transcripts by 
transfection with pSG5 Tgase. C. Immunofluorescent staining images. Red: TGM-2. D. Western 
blot showing immunoreactivity against TGM-2. E. Top: Vector map for pSM2 TGM2. Middle: 
Real time PCR. Down-regulation of TGM-2 transcripts when HCE-T were transfected with 
either PEI and Fugene VI reagents for 24 hours, Bottom: Down-regulation of TGM-2 when  





2.3 Global gene expression 
To evaluate the global gene expression profiles in pterygium, samples were 
processed as described in the Appendix A17 and evaluated with the Affymetrix 
U133A Genechip. Because the amount of RNA used in this GeneChip experiment 
was only 100 ng instead of the 1 µg, the step for removal of ribosomal RNA was 
omitted. Briefly RNA sample preparation was performed according to the Affymetrix 
standard protocol. Fifteen micrograms of biotin-labelled cRNA using BioArray RNA 
Transcript Labelling Kit (ENZO Life Sciences, NY) were fragmented and the 
appropriate volume injected separately into the probe array chips.  
The transcripts were hybridized onto the immobilized oligonucleotide 
sequence on the array for 16 hours at 45°C under 60 rpm rotation using GeneChip 
Hybridization Oven 640. Washing and Strepavidin-staining steps were performed 
using the Affymetrix Fluidics Station 450. The chips were scanned using GeneChip 
Scanner3000. 
The Robust Multi-array Average (RMA) model was used to extract the gene 
expression signals from probe intensities without taking the mismatch probe signals 
into consideration. Cross-array normalization was performed using the intensity-based 
log ratio median method for all samples (4 normal conjunctiva samples and 9 primary 
pterygium samples) using the first array as the reference. Data were visualised and 
explored using the GeneSpring GX 7.3 platform (Agilent Technology, Redwood City, 
CA). Gene expression profiles of pterygium tissue and un-involved conjunctival 
tissue were uploaded to the Gene expression omnibus (http://www.ncbi.nlm.nih.gov, 
GDS1758, GSE2513 and GPL96). 
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To understand the role of TGM-2 in gene regulation in cultured corneal 
epithelial cells an unbiased global gene expression study was performed. The human 
exon array from Affymetrix was used. The details of this procedure can be found in 
the Appendix A17. Human corneal epithelial cells (HCE-T) were cultured in 10 cm 
plates and cells were either transfected with the pSG5 Tgase plasmid, which over-
expressed TGM-2, or the pSG5 plasmid without insert (control). Details of cell 
culture are provided in Appendix A1. Experiment was performed under identical 
conditions on 3 different occasions. Details of transient transfection using the FuGene 
VI transfection reagent are provided in Appendix A4. Cell lysis and RNA extraction 
are described in Appendix A7. All RNA extracted were subjected to evaluation by gel 
electrophoresis (Figure 2 A) as well as analysis using the Bioanalyser. Before 
performing the microarray experiment, reverse transcription real time polymerase 
chain reaction (PCR) was also performed to ensure that the TGM-2 transcript levels 
were significantly elevated (p<0.05) in all experiments relative to control. In the 3 
independent experiments (biological replicates) performed, the transcript levels of 
TGM-2 were elevated by more than 100 fold in the cells over-expressing TGM-2 
compared to cells transfected with the control vector. Details of the PCR method can 
be found in the Appendix A14.  
Data analysis for the human exon array GeneChip experiment was performed 
using the Partek Genomic Suite version 5.0 (Partek Inc, St Louis, MO). After 
scanning, the data in the CEL files underwent RMA normalisation and were imported 
into the software spreadsheet. Only a subset of probes belonging to the Affymetrix 
extended metaprobeset was analysed. This consisted of probes for half a million 





Figure 2. A. Image of gel after electrophoresis of total RNA. Top black arrow corresponds to the 
bands due to 28S ribosomal RNA and the bottom black arrow corresponds to the bands due to 
18S ribosomal RNA. The intensity of the bands vary due to different amounts of total RNA 
loaded (same volume, different concentrations). TGM-2 + indicates samples with over-expression 
of TGM-2, other samples are controls transfected with the empty pSG5 vector. Exp 1, 2 and 3 are 
replicate experiments transfected and RNA collected on different days. B. 3-D scatter diagram 
showing the results of principal component analysis. The first 3 principal components are shown 
in the axes, batch effect was removed for the data displayed. 
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 In order to compare expression levels of different transcripts (as opposed to 
exons), the mean expression level of the exons mapped to each specific transcript was 
calculated. To perform global profiling, the principal component analysis and plotting 
of 3D scatter diagrams were performed. The 3D scatter diagram was also plotted after 
removing the batch effect (Figure 2 B). Significance of differential expression was 
evaluated using the paired T test procedure, since the batch effect (differences in 
expression between experiments performed on different occasions) must be accounted 
for. 
The alternate splice analysis of variance (ANOVA) procedure from the 
software was used to evaluate differential splicing of transcripts. The mathematical 
basis of this ANOVA model is summarised by the following equation: 
Y= µ + T + P + E + T*E + S(P+T) +  ε 
In the above equation, Y represents the observed variation or expression level, 
the first three terms (µ , T , P) are identical to the terms in 2 way ANOVA or the 
paired T test,  where µ is the average tissue independent expression level, T is the 
tissue or condition specific expression level, and P is the batch effect. In the paired T 
test, the T term represents the differential expression of the transcript for cells over-
expressing TGM-2. 
In the second part of the equation, E represents exon to exon variability (tissue 
or condition independent alternate splicing, in this case: alternate splicing unrelated to 
the expression status of TGM-2), T*E represents tissue- or condition-dependent 
alternate splicing (interaction of the exon term and the cell treatment, in this case: 
alternate splicing dependent on TGM-2 status), S(P+T) represents the variability 
related to individual samples (nested with batch and cell treatment), and ε the other 
variability not explained by the above terms.  
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Therefore, of the various p values generated by the software, the p value for 
the T*E was of greatest interest because that indicates differential splicing related to 
the over-expression of TGM-2. For ease of examination, the transcripts were sorted 
by ascending p values, beginning with the transcripts with the smallest p values. 
These transcripts are of the greatest interest because they showed significant alternate 
splicing induced by TGM-2 over-expression. 
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2.4 Transglutaminase as cross-linking enzyme 
Unlike the more ‘conventional’ signaling mechanisms employing non-
covalent interaction between protein domains, the details of intracellular signaling 
resulting from covalent cross-linking of molecular substrates are relatively poorly 
understood. More elaborate biochemical techniques are required to study this form of 
signal transduction. It is well known that certain substrates (neighbourhood sequences 
of the lysine and glutamines) have higher affinity for TGM than others (Madi et al 
2001). The transamidase function can be evaluated by first adding a cell-permeable 
pseudo-substrate. After transamidation, the pseudo-substrates will have been 
covalently cross-linked to cellular molecules and unlike the free pseudo-substrates, 
will not be washed away. The second step involves assessment of the amount of 
pseudo-substrate incorporation by the enzyme into the other cellular molecules. In the 
situation where fluorescein cadaverine is used as the pseudo-substrate (see Appendix 
A5), the fluorescence detected by imaging the cells is a measure of TGM activity. 
Note that all forms of TGM contribute to TGM activity, not just TGM-2.  
Mutant forms of TGM-2 deficient in transamidase function but not GTPase 
function can also be expressed. The endogenous wild type TGM-2 in these transfected 
cells however, can still demonstrate transamidase activity at a very low level if un-
stimulated. The Cys277Ser mutant is not dominant negative. 
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CHAPTER III. GLOBAL GENE EXPRESSION  
3.1 Global gene expression in pterygium tissue 
Pterygium is a relatively common human ocular surface disease characterised 
by a visible wedge-shaped fibrovascular proliferation and problems of secondary dry 
eye, astigmatism and even occlusion of visual axis. The main method of treatment for 
this condition is surgical resection, but in a number of cases aggressive recurrence can 
result after excision. In places with a high prevalence of pterygium (such as equatorial 
countries and locations with a lot of exposure to sunlight), this may be the most 
frequent ophthalmic surgery after cataract excision and refractive surgery. A previous 
study has implicated TGM-2 in this disease (Kim et al 1998). 
There has been no concensus on the mechanism of pterygium formation. 
Theories include injury response to ultraviolet light, elastotic degeneration of 
connective tissue matrix, inflammation, dysregulation of apoptosis, dyslipidemia, 
genetic instability, stem cell disorder and epithelial mesenchymal transition (Kwok et 
al 1994). 
This disease appears to be a uniquely human condition, as no animal model 
exists at present. Conventional approaches to the study of disease mechanisms can 
only address one or two hypotheses at a single setting, and may not be able to 
decipher the relative contribution of different pathways to this likely multifactorial 
disease. Because of the above considerations, an un-biased global gene expression 
study is used to commence the investigation into pterygium mechanisms and the 




Details of the methods of the pterygium microarray study are provided in 
Chapter II and the Appendix A17. TGM-2 transcript level was down-regulated in 
pterygium tissue compared to un-involved conjunctiva. A detailed examination of the 
various classes of genes that are differentially regulated is beyond the scope of this 
thesis. Real time polymerase chain reaction after reverse transcription was used to 
validate the microarray findings. This showed that the expression of TGM-2 
transcripts in pterygium was 0.40 fold (significantly reduced) compared to that of un-
involved conjunctiva. Immunohistochemistry for TGM-2 revealed that the basal 
lamina expression of TGM-2 protein in normal conjunctiva was diminished in 
pterygium epithelium (Figure 3). The methods of the immunofluorescence study are 




Figure 3. Immunofluorescence pictures showing TGM-2 in the normal ocular surface epithelium 




In this study, the following hypotheses for the mechanism of pterygium 
formation were enumerated and this defined the corresponding gene ontology 
categories (molecular function, cellular compartment, or biological function) within 
parentheses: 
1. Apoptosis dysfunction: ‘Cell death’ 
2. Dysregulation of connective tissue: ‘Extracellular Matrix’ 
3. Oxidative damage: ‘Oxido-reductase’ 
4. Lipid dysfunction: ‘Lipid metabolism’ 
5. Epithelial mesenchymal transition: ‘Wnt receptor signaling’. 
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Restricting to the above gene ontology categories, the differentially regulated 
genes (defined as a change of at least 2 fold and statistically significant at the level of 
alpha = 0.05) for each of the postulated hypotheses were sequentially exported to the 
Pathway Studio 5.0 software (Ariadne Genomics Inc, Rockville, MD). Similarly, the 
expression ratios for TGM-2 were exported into Pathway Studio. The option ‘Find all 
shortest paths between selected entities’ was selected in order to extract known 
biological entities that are linked to the selected entities in each hypothesis to 
construct a pathway. The software extracted related entities and relations in web-
based databases of genes, proteins and pathways that directly or indirectly linked the 
entities corresponding to the imported differentially regulated genes. For this purpose, 
the ‘number of connectivities of 2 or less’ was selected to reduce computing time. 
Wherever necessary, the entities that were found by the software to be connected 
were evaluated in the original gene expression data to check whether these genes were 
also differentially regulated in pterygium. 
The pathway approach aims to answer the following questions: 
1. Is TGM-2 linked to the differentially regulated genes under a functional 
category, eg., regulation of apoptosis? 
2. Are there many relations between TGM-2 and these dysregulated genes? 
3. Are the dysregulated genes or their downstream entities able to explain 
disease phenotype? For example, matrix metalloproteinases may explain the invasive 
property of this ‘tumour’, the presence of caspases may explain the apoptotic 
phenotype.  
4. How many intervening nodes or steps are found between TGM-2 and these 
disease effectors in (3) above? 
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The underlying assumption in these analyses was that the occurrence of many 
differentially regulated genes in the same pathway implicates the pathway in the 
mechanism of the disease. Secondly, if TGM-2 is linked to these networks, it is 
assumed to play a likely role in that pathological process. The more direct and more 
ways TGM-2 is linked, the more important the role of TGM-2 in the process. One 
limitation of this procedure is that only known relationships in the published literature 
can be discovered, and most of the known literature involve non-ocular surface cells 
and tissues.  
In gene expression data, the direction of the differential regulation in 
pterygium may be less useful than it appears. One has to bear in mind that gene 
expression data are not the same as protein level data or protein activity levels. In 
other words, up regulation and down regulation of genes may not be indicative of 
increased or decreased biological function respectively. For example, increased 
biological function of a protein due to phosphorylation or protein folding may 
actually be associated with down-regulation of the gene if there is negative feedback 
processes. 
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Figure 4) showed that TGM-2, together with other connective tissue genes 
were differentially regulated, supporting a hypothesis of aberrant wound healing as 
well as dysregulation of cell death. Using a pathway approach to the analysis of gene 
expression data, it was found that TGM-2 was linked to a network of signaling 
molecules related to wound healing and regulation of apoptosis (Error! Reference 
source not found.). For simplicity, the networks involved in other pathways such as 





Figure 4. Pathway analysis of global gene expression data. TGM-2 down-regulation may result 
from upstream changes and affecting wound healing. Red and green symbols show genes up- and 






Figure 5. Pathway analysis in pterygium. Top: The differentially expressed genes related to 
‘apoptosis’ are exported to Pathway Studio so that relations to effectors and upstream regulators 
are illustrated. Bottom: The same analysis was repeated with wound healing and matrix related 
genes. Red and green symbols represent genes up and down regulated respectively, in primary 
pterygium relative to un-involved conjunctival tissue. Purple symbols represent known relations 
from protein binding studies. 
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 Using the same pathway approach, the direct pathway relationships that are 
known to be linked to TGM-2 under different hypotheses and networks for functional 
categories are extracted and shown (Figure 5).  
 
Figure 5. Entities connected directly to TGM-2 in pathway analysis. Note that the majority of the 
downstream entities are concerned with modulation of extracellular matrix (ECM) or with 
control of cell death/proliferation. 
Considering all the factors (number of connections, etc) listed above, TGM-2 
performs a greater role in the apoptotic and wound healing (extracellular matrix 




How will apoptosis and modulation of extracellular matrix play a role in 
pterygium pathogenesis? Pterygium is concerned with excessive proliferation of 
fibrovascular tissue. The reduction in apoptosis or aberrant apoptosis may cause an 
imbalance in the overall numbers of cell types within pterygium, with a tendency 
towards increased cellular proliferation (Tan et al 2000). This is also supported by the 
abnormal expression of p53 in pterygium (Weinstein et al 2002). Increased fibrobasts 
may explain the fleshy appearance of the pterygium, due to the excessive deposition 
of matrix within the abnormal tissue. The proliferation of vascular endothelial cells 
into the pterygium tissue may explain the clinically observed vascularity, injection 
and hyperemia. Pterygium tissue, especially at the head of the lesion, may invade into 
the corneal Bowman’s layer and into the superficial corneal stroma. This process of 
invasion may be facilitated by dysregulation of matrix metalloproteinases and other 
proteases secreted in pterygium (Di Girolamo et al 2003). 
A word of caution is necessary. The analysis was aimed to explore the 
contribution of TGM-2 in various proposed mechanisms, but was not designed to 
evaluate the relative merit of each mechanism in pterygium formation. TGM-2 plays a 
less significant role in processes like Wnt signaling compared to apoptosis and 
extracellular matrix modulation. This does not imply that aberrant Wnt signaling and 
epithelial mesenchymal transition are not contributing to pterygium. In fact, another 
research group has put forward evidence of epithelial mesenchymal transition in the 
pathogenesis of pterygium, where the fibroblasts may originate from basal epithelial 
cells of conjunctival epithelium (Kato et al 2007).  
Pterygium is likely to be a multi-factorial disease, involving parallel 
processes, with the mediation of TGM-2 directly or indirectly. In a later chapter 
27 
(Chapter 5.3) another molecule in lipid metabolism that may be responsible for the 
horizontal migration of tissue in pterygium will be described. 
The main difficulty in the interpretation of this gene expression study is 
related to the differential cell type composition between the pterygium specimen and 
the un-involved conjunctiva tissue. The experiment could not compare ‘normal’ 
conjunctival epithelial cells with ‘diseased’ conjunctival epithelial cells. Some of the 
differences in gene expression, or perhaps most of the differences detected may be 
attributed to the higher proportion of fibroblasts and vascular tissue in the pterygium 
specimens, which are absent in the biopsy of the ‘un-involved conjunctival tissue’.  
Although there was difficulty in the interpretation of the experimental results, one 
must remember that this approach really reflected the nature of the pathology. This 
ocular surface disease might be caused by an imbalance in the cellular composition of 
tissue to begin with. 
Any experimental findings or interpretations from microarray studies should 
be subjected to validation with a different technique or independent studies. In this 
case a different type of GeneChip experiment in cultured cells was undertaken 
(Chapter 3.2) followed by a variety of laboratory techniques in a cell culture model 
(Chapters IV-V). The main aim of these subsequent experiments is to establish the 
role of TGM-2. In terms of investigating real ocular surfaces diseases, these 
approaches have the disadvantage of not including interactions between different cell 
types or cell-matrix interactions, which may be crucial in the pathology. 
 
3.2 Global gene expression in cells expressing TGM-2 
In order to further delineate gene expression that is related to the effect of 
TGM-2, the gene expression profile of cultured human corneal epithelial cells over-
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expressing TGM-2 was compared to control cells (transfected with the empty vector). 
The methodology for this study is described in Chapter 2.3. Briefly, a gene level 
summary was obtained using the Affymetrix extended metaprobeset. This procedure 
analysed 500 000 exons on the Genechip and matched these exons to 130 737 
transcripts. Apart from well known genes with identified protein products, these also 
include transcripts for hypothetical genes and proteins, pseudogenes, and those 
partially composing of predicted exons, etc.  Principal component analysis was 
performed to profile the global gene expression. When batch effects have been 
removed by the software, a clear separation could be seen in the gene expression in 
cells that have TGM-2 over-expression or otherwise. A paired T test was performed 
for 3 sets of experimental samples, and 5408 transcripts were found to be 
differentially regulated when TGM-2 was over-expressed (p<0.05). 
Limiting the analysis to differentially regulated known genes (p<0.05) with at 
least 20% level of change, and excluding genes coding for hypothetical proteins, 9 
transcripts were up-regulated and 15 were down-regulated (Table 1). Examples of up-
regulated transcripts (Figure 6) include those coding for the late cornified envelope 




Figure 6. Transcript level changes after TGM-2 over-expression using pSG5 Tgase transient 
transfection. A. Microarray fold change data for late cornified envelope protein 2B (LCE2B), the 
horizontal axis shows the relative fold change, B. Bar chart showing real time PCR transcript 
levels for LCE2B normalised to control (transfection control), Bars represent means of 2 
experiments, error bars indicate standard deviations. C. Microarray fold change data for keratin 
associated protein (KAP)9-3, D. Real time PCR transcript levels for KAP9-3, E. Microarray fold 
change data for microRNA124.  
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The transcript coding for a microRNA stem loop: hsa-mir-124a-3 
(MI0000445) was found to be the most significantly up-regulated transcript. Since a 
few hundred microRNA is believed to regulate as much as a third of the human 
genome (Engels et al 2006), TGM-2 may have far reaching effects on the regulation 
of global gene expression. The target mRNA for this microRNA in human corneal 
epithelial cells is currently not known. 
To analyse possible differential splicing of transcripts the Alternate Splice 
ANOVA procedure was performed as described in Chapter 2.3, on the human exon 
array. This analysis shows that 2115 transcripts had differential splicing when TGM-2 
was over-expressed. This corresponds to transcripts from 1058 known genes 
including those coding for predicted proteins, and 912 known genes with known 
protein products. Amongst the 2115 transcripts, only 105 transcripts have 
significantly up or down regulated transcript levels between cell treatment (whether 
TGM-2 over-expressed) at p<0.05. This included 32 transcripts from known genes 
and only 24 of these genes code for known proteins. The data therefore show that in 
the majority of transcripts, regulation of transcript level and alternate splicing are 
distinct regulatory events. The next section describes some examples of alternate 
splicing regulated by the over-expression of TGM-2. 
Human defensins are secreted into tears that bathe the human ocular surface, 
and play a key role in the innate immunity of the eye (Harvey et al 2005). Over-
expression of TGM-2 was associated with a significantly increased rate of splicing 
out or exclusion of the third exon of the human β-defensin 119 peptide, which 
encodes the C terminal third of the defensin peptide. If the shortened transcript is 
translated, the product would be expected to have a reduced net charge from +2 to –1, 
increased hydrophobicity, reduction of isoelectric point from 7.2 to 4.4. Because of 
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the loss of cysteine residues at position 35 and 39, some disulphide bridges may also 
be lost. Alteration of defensin hydrophobicity may be associated with reduced anti-
microbial potency (Kluver et al 2005). 
IL17 is a modulator of MMP1 and chemokines production by corneal 
fibroblasts in herpetic stromal keratitis (Maertzdorf et al 2002), especially in 
combination with TNF-α. This can increase the subsequent massive infiltration of 
neutrophils and the inflammation within the tissue. In the exon array study, over-
expression of TGM-2 was found to increase the incorporation of two exons in the 
transcript of IL17F, a member of the IL17 family. The first of these exons is located 
in the 5’ un-translated region, and the other in the protein-coding region of the 
transcript. Without these exons in the transcript, there may not be translation into the 
full length IL17F. Therefore, over-expression of TGM-2 encourages formation of the 
full length IL17F. Currently IL17F transcripts have been detected in human corneal 
epithelial cells in culture, and immunofluorescent staining and Western blot has 
revealed the presence of IL17F protein (data not shown). It remains to be shown 
whether the alternate splicing of IL17F transcripts has any functional effects. 
In a non-ocular context, IL17F has been shown to be induced in a dose and 
time dependent way (Ye et al 2001) in response to gram-negative bacteria such as 
Klebsiella pneumoniae, which is also a known pathogen in the human cornea. 
Although preliminary, our findings suggest that TGM-2 function may be associated 
with reduced defensin associated anti-microbial defense but increased IL17F related 
inflammation in viral-induced infections of the ocular surface. 
At this moment of time, it is unclear how the TGM-2 can induce alternate 
splicing of transcripts. TGM-2 may directly or indirectly affect the spliceosome 
mechanism or the function of splicing regulating proteins. 
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One example of alternate splicing occurs in the zinc finger protein (ZNF) 621 
which is a negative regulator of gene transcription. Interestingly, the data shows that 
the first part of the first exon (-223 to –123bp) and the second part of the same exon (-
122 to –62) were included differentially in the final transcript. When TGM-2 was 
over-expressed, the second part of the exon (-122 to –62) was included at a 
significantly more frequent rate whereas the converse was true for the first part of the 
exon (-223 to –123). In other words, the more downstream regulatory region was 
preferred when TGM-2 was over-expressed. The biological significance of this is 
currently unknown, but the rate of transcription may possibly be altered by TGM-2 
over-expression since proteins binding here can potentially influence the 
transcriptional complex. 
Another transcript with differential splicing was COLV3A. This codes for the 
alpha chain of a low abundance fibrillar collagen Collagen Type V. Collagen Type V 
is similar to Type XI, and is located in specific tisssues expressing Collagen Type I. 
Mutations of this genes have been implicated in Ehlers Danlos Type III. The single 
alpha chain contains 19 Pfam collagen domains which have the function of binding 
carbohydrates. The 26th exon in the transcript may be included or not depending on 
splicing events. The data show that when TGM-2 was over-expressed, this exon was 
significantly more likely to be included. The exon codes for residues 687-695 in the 
middle of the 5th Pfam collagen domain (normally residues 665-724). The biological 
significance of this event is unknown. Since the function of the Pfam collagen domain 
is mainly for binding sugar moieties, it is possible that a certain level of TGM-2 in 
cells and tissues is necessary for glycoprotein formation. I therefore speculate that 
down-regulation of TGM-2 in disease may also affect stability of matrix assembly in 
wound healing. 
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Why is over-expression used in this experiment? In view of the endogenous 
expression of TGM-2, an alternative is to use a TGM-2 silencing strategy. However, 
TGM-2 over-expression may be advantageous because many TGM-2 roles in 
pathology result from gain-of-function and may not manifest in the un-stimulated 
state. For example, cultured cells stressed by UVB have increased TGM-2 levels (see 
Chapter 4.2). Increase in TGM-2 function may be due to an increased in transamidase 
activity, GTPase activity, or unrelated to either of these. Some cellular functions of 
TGM-2 such as interaction with fibronectin do not require enzymatic functions 
(Zemskov et al 2006), and may be revealed by over-expression. It is possible that 
over-expression also yield effects dependent on transamidase activity, in which case 
silencing of TGM-2 and over-expression of the Cys277Ser mutant may be helpful. 
In summary, TGM-2 function may be related to microbial defense as well as 
extracellular matrix structure and adhesion in the ocular surface. However, these 
experiments are based on over-expression of TGM-2 in a cell line, and it is difficult to 
extrapolate this to physiological or even pathological levels of TGM-2 in human 
tissues or in patients. Nevertheless, these studies suggest several novel mechanisms, 
such as RNA interference and alternate splicing which may have relevance in human 
ocular surface physiology or diseases. Currently, the functional implications of some 
of the above findings are being investigated. Despite having a well-defined gene locus 
and transcript, the detection of βdefensin 119 protein has not yet been reported.  
Immunohistochemical studies of IL17F and antimicrobial activity of different 
lengths of β-defensin 119 peptides are being conducted. In addition, RNAi studies 
will be conducted in the future to evaluate the role of the microRNA hsa-mir-124a-3 
in the ocular surface. Currently, the mRNA targets for this microRNA are not known, 
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and a study involving deletion of this microRNA using a RNA interference approach 
is currently planned.  
Key findings: 
 
• Pterygium, a fibrovascular proliferative disease, is characterised by silencing 
of TGM-2 in the basement membrane of the epithelium, as well as 
dysregulation of many genes concerned with extracellular matrix regulation, 
for example COL4A1 and MMP2 
• Down regulation of TGM-2 is linked to a network of other related genes in 
pterygium, which causes aberrant wound healing and decrease in cell death 
• Over-expression of TGM-2 in cultured human corneal epithelial cells 
upregulated miR-124a-3, late cornified envelope 2B and keratin associated 
protein 9-3 
• Over-expression of TGM-2 was associated with alternate splicing of 
transcripts like IL-17F, but the functional consequence of this alternate 








Table 1 A (below). Up-regulated genes in cells over-expressing TGM-2 (p<0.05) 
Accession Gene Name 
No of folds up-
regulated Description Function 
AK024111 HCG11 1.42 HLA complex group 11 Immune response 
NM_178547 ZBTB8OS  1.35 zinc finger and BTB domain containing 8 opposite strand  Transcription 
NM_207043 ENSA 1.33 endosulfine alpha  Transport 
NM_024021 MS4A4A 1.29 membrane-spanning 4-domains, subfamily A, member 4  Receptor activity 
NM_014357 LCE2B  1.26 late cornified envelope 2B  NM_178429  Epidermis development 
NM_031962 KRTAP9-3 1.26 keratin associated protein 9-3 Keratin filament 
NM_001029888 FAM24A 1.25 family with sequence similarity 24, member A // 10q26.   
NM_181837 ORC3L  1.22 origin recognition complex, subunit 3-like (yeast) // 6q14 DNA repair 
NM_032566 SPINK7  1.21 serine peptidase inhibitor, Kazal type 7 (putative)  Endopeptidase inhibitor 
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Table 1B (below). Down-regulated genes in cells over-expressing TGM-2 (p<0.05) 
 
Accession Gene Name 
No of folds 
downregulated Description Function 
NM_012404  ANP32D -1.67 acidic (leucine-rich) nuclear phosphoprotein 32 family   
NM_001004489  OR2AG1 -1.49 olfactory receptor, family 2, subfamily AG, member 1 Signaling 
NM_007077 AP4S1 -1.43 adaptor-related protein complex 4, sigma 1 subunit Signaling 
CR617006 HNRPA1P5 -1.38 
heterogeneous nuclear ribonucleoprotein A1 
pseudogene 5    
NM_001002246  ANAPC11 -1.27 
APC11 anaphase promoting complex subunit 11 
homolog Protein degradation 
NM_181622  KRTAP13-3 -1.26 keratin associated protein Keratin filament 
NM_001009609  SPANX-N3 -1.25 SPANX-N3 protein   
NM_006367 CAP1 -1.23 adenylate cyclase-associated protein 1 (yeast) // 1p34 Signaling 
CR749375 EPC1 -1.23 enhancer of polycomb homolog 1 (Drosophila)  Transcription 
AL110103 AP3S2 -1.23 adaptor-related protein complex 3, sigma 2 subunit Signaling 
ENSESTT000000
43194   IL12A -1.22 interleukin 12A (natural killer cell stimulatory cytokine) Immune response 
NM_001033018 DEFB137 -1.21 beta-defensin 137 Immune response 
CR593195 USP1 -1.20 ubiquitin specific peptidase 1 Protein degradation 
NM_152943  ZNF268 -1.20 zinc finger protein 268 Transcription 
BC020443 CIB2 -1.20 calcium and integrin binding family member 2  Calcium binding 
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CHAPTER IV. TRANSGLUTAMINASE AND APOPTOSIS 
4.1 Introduction to apoptosis 
4.1.1 Definition of apoptosis 
 
Apoptosis, or programmed cell death, is a type of cell death characterised by a 
set of morphological features as well as the activation of enzymes called caspases. 
These morphological features include swelling of cells, blebbing of cell membranes, 
and the formation of nuclear fragments and apoptotic bodies. Caspases are cysteine 
proteases which cleave substrates such as lamin and caspase-activated DNase (CAD). 
Cleavage of lamin in nuclear envelopes results in nuclear fragmentation. Activation of 
CAD results in cleavage of cellular DNA between nucleosomes, consequently 
producing the commonly described 100-200 base pair DNA fragments. Other caspase 
substrates, when cleaved, can contribute to changes such as membrane blebbing. 
Because apoptosis can be initiated by cell surface receptors as well as cell intrinsic 
factors (such as DNA damage), apoptotic signaling has been divided into the extrinsic 
and mitochondrial pathways respectively. However, activation of the two pathways 
may occur in parallel or in tandem. Unlike death pathways such as necrosis, apoptosis 
is generally not associated with much inflammation because the dead cell material 
may be efficiently removed, either by shedding and drainage into tears, or via 
phagocytosis in macrophages. 
4.1.2 Apoptosis in the ocular surface 
In previous work, it has been shown by one of the collaborators (SCP; see 
acknowledgements) that apoptosis is involved in experimental dry eye (Yeh et al 
2003). In this study, experimentally induced dry eye in mice caused apoptosis of cells 
in ocular surface tissues including the central and peripheral corneal epithelium, 
bulbar and tarsal conjunctival epithelia, tarsal conjunctival stroma, the lid margin as 
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well as the accessory lacrimal glands and goblet cells responsible for tear secretion 
(Yeh et al 2003). Another evidence from the same collaborator (SCP) showed that 
hyperosmolarity (150-200 mOSM higher than 312mOsM) significantly induced 
human corneal epithelial cell apoptosis evidenced by ApopTag In Situ Oligo Ligation 
assay, as well as stimulated the release of cytochrome c and the second mitochondrial 
activator of caspase (SMAC) from the mitochondria. Such stimulation also activated 
caspase 3, interleukin-1β converting enzyme, and other apoptosis related genes 
including caspase 2,8, p53, bak and fas. 
4.1.3 Role of transglutaminase in apoptosis 
TGM-2’s role in apoptosis is found to be very context dependent. In cancer 
cells, it promotes survival signaling by interacting with extra-cellular matrix 
molecules (Yuan et al 2005, Mehta et al 2006). In fact, TGM-2 may be a type of 
inhibitor of caspase-3 in a non-ocular scenario (Yamaguchi et al 2006). In 
hepatocytes, it is part of the adrenergic receptor signaling pathway that facilitates the 
expression of BCL-XL, an anti-apoptotic protein (Sarang et al 2005). In most other 
cells, it is known to be an effector of cell death; for example, it may enhance 
mitochondrial pore formation via the polymerization of BAX (Fesus et al 2005). 
Lately, it has been found that TGM-2 can induce the apoptotic inducing factor, 
triggering a non-caspase dependent form of cell death (Fok et al 2007). The apoptotic 
effect of TGM-2 may also be dependent on sub-cellular localization. Nuclear TGM-2 
may be anti-apoptotic, whereas cytoplasmic TGM-2 may be pro-apoptotic (Milakovic 
et al 2004). 
4.1.4 Transglutaminase and the mitochondria 
 
The mitochondria is a well-known sensor of external stimuli for the trigger of 
apoptosis; as well as an endogenous source of reactive oxygen species and hence, 
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oxidative stress (Battaglia et al 2006, Gutierrez et al 2006). Apart from its role in the 
polymerisation of BAX mentioned above (Fesus et al 2005), TGM-2 has also recently 
been found to belong to the class of BH3-only apoptotic regulatory proteins that 
critically regulates the mitochondrial apoptotic pathway, being anti-apoptotic in the 
absence of stress, but becoming pro-apoptotic in the presence of stress-induced 
signaling and raised calcium concentrations (Rodolfo et al 2004). TGM-2 sensitises 
neuronal cell lines to apoptosis by increasing the mitochondrial membrane potential 
and cellular oxidative stress (Piacentini et al 2002). 
One of the hypothesis of mitochondria apoptosis is the energy deprivation 
hypothesis. The mitochondria is the energy house of the cell, and malfunction of ATP 
production may initiate the apoptotic pathways. Recently, this energy function of the 
mitochondria has been linked to TGM-2 (Battaglia et al 2006). By regulating ATP 
synthesis, TGM-2 may also protect cells against some types of injury such as 
ischemia (Szondy et al 2006).  
TGM-2 contributes to the formation of disulphide bridges in the respiratory 
complexes in the mitochondria, contributing to the correct assembly of these 
complexes(Mastroberardino et al 2006). TGM’s transamidase activity on a 
mitochondrial substrate aconitase is known to play a role in neurodegeneration (Kim 
et al 2005). Hepatocytes stimulated with ethanol were shown to have released 
cytochrome c from their mitochondria in a TGM-2 dependent fashion (Song et al 
2003). 
Despite the fact that TGM-2: mitochondria interactions represent an attractive 
target (Szeto 2006) for treating ocular surface inflammation, these processes have not 
been studied in an ocular surface cell. Studies in murine brain and liver have found 
that the TGM activity in the mitochondria was not due to TGM-2 but due to an un-
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identified TGM isoform (Krasnikov et al 2005), but this finding has not been 
investigated in human ocular surface cells. 
 
4.1.5 Ultraviolet light-induced apoptosis 
UVC (Lu et al 2003) and UVB (Shimmura et al 2004) radiation have been 
known to stimulate apoptosis in corneal epithelial cells. In rats that have undergone 
irradiation, corneal cells express JunB, with evidence of apoptosis in the stroma as 
well in the epithelium (Wickert et al 1999). Although TGM-2 expression has been 
known to be triggered by ultraviolet radiation and other oxidative stresses, the precise 
mechanism is unknown, and the resulting TGM activity is highly cell type dependent 
(Shin et al 2004). For these reasons, I think the UVB model is excellent for the 
evaluation of stress responses in ocular surface epithelial cells, especially in the 
context of TGM-2 pathways.  
Currently, there is great controversy about the mechanism of TGM-2 in 
apoptosis in various cell types in response to different stimuli (Milakovic et al 2004, 
Rodolfo et al 2004, Fesus et al 2005, Sarang et al 2005, Yuan et al 2005, Mehta et al 
2006, Yamaguchi et al 2006).  
Despite the relevance of apoptosis in the ocular surface, the possible roles of 
TGM-2 in apoptosis or mitochondrial dependent apoptosis have not been explored. In 
order to explore the possibility of a TGM-2 based strategy for treatment of ocular 
surface disease, its role in apoptosis, and in particular, the mitochondrial apoptotic 
process, has to be better understood in the context of the ocular surface. To address 
that, experiments were conducted to evaluate firstly, the effect of UVB in corneal 
epithelial cell viability, and secondly, the possible role of TGM-2 in this process. 
Thirdly, the presence of TGM-2 in mitochondrial fraction of corneal epithelial cells 
and binding of TGM-2 to mitochondrial proteins were studied. 
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4.2 UVB induced apoptosis in corneal epithelial cells 
 
The effect of UVB on cultured corneal epithelial cells is dependent on dosage 
of energy and duration of incubation after the stimulus. The energy of UVB delivered 
depends on the power of the UVB lamp, the distance between the lamp and the 
cultured cells, as well as the duration of exposure of the cells to UVB. The 
experiments investigating the dose effect of the UVB on cell are described in the 
Appendix B. 
Unless otherwise stated, the dose of UVB used in the following experiments is 
20 mJ/cm2. Irradiation was preceded by the removal of the culture medium from the 
culture wells. In order to deliver the required dose of radiation, exposure time is 
usually about 30 seconds. A UVB dosimeter with a mid UV detector was used for 
calculation of exposure time in each experiment. Before returning cells to incubation, 
the culture medium was replaced. 
24 hours after UVB with the above dose, about 80% of the cells were still 
viable. This has been verified using the MTT test (see Appendix) as well as 
trypsinisation and cell counting on the haemocytometer. 
The next figure shows aspects of caspase-3 activation as well as apoptosis 
(Figure 7). The extent of caspase-3 activation is increased at 6 hours (A) and at 16 
hours (data not shown) after irradiation. In the presence of MDC, a TGM inhibitor, 
the caspase-3 activation was kept low after UVB. The proportion of TUNEL staining 
cells was increased at 24 hours after UVB (B). Similarly, this proportion was kept low 
for cells incubated with MDC. TUNEL stained cells corresponded to the fragmented 
nuclei stained by propidium iodide (C). Figure 8D shows the features of an apoptotic 
cell after exposure to UVB. 
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Figure 7. Apoptosis induced by UVB in human corneal epithelial cells. A. The percentage of cells 
staining for active caspase-3 was counted and presented in a plot. MDC: monodansyl cadaverine 
(cell permeable competitive inhibitor of transglutaminase). B. Chart showing proportion of 
TUNEL staining cells. C. Color images showing green (TUNEL staining) and red (propidium 
iodide staining) cells. D. Electron micrographs. The morphology of corneal epithelial cells 
growing on limbal explants was investigated after UVB using electron microscopy. Left: blue 
arrow shows membrane blebbing. Right Solid arrows show intact organelles in cytoplasm. 
Hollow arrow shows cleavage of nuclear lamin in the nuclear lamina.  
 
 Figure 8. Effect of UVB on transglutaminase. A. TGM-2 transcript levels determined by real 
time polymerase chain reaction, values expressed as fold change relative to control cells 
unexposed to any UVB or transfection. SiF: non-silencing SiRNA conjugated to fluorescein. 
SiTGM-2: Short interfering RNA (synthetic oligonucleotides) specific for TGM-2 transcripts. B. 
Immunofluorescent staining images showing an increase in TGM-2 protein detection 24 hours 
after UVB. C. Fluorescein cadaverine uptake assay showing increase in transamidase activity 
after UVB. MDC: monodansyl cadaverine, a cell permeable competitive inhibitior of TGM.  
 
43 
4.3 Transglutaminase in corneal epithelial cell apoptosis 
 
UVB was found to increase TGM-2 transcript, protein and activity levels ( 
Figure 8). The transcript levels were determined using real time PCR (Figure 9A), 
the protein levels were evaluated using immunocytochemistry (Figure 9B) and 
Western blot (data not shown), and the transamidase activity was determined using 
the fluorescein cadaverine uptake assay (Figure 9C). Details of 
immunocytochemistry, Western blot and transamidase assay can be found in the 
Appendices A9, A10 and chapter 2.4 respectively. Briefly, the amount of fluorescence 
detected was a directly related to the TGM activity within the cells. Silencing of 
TGM-2 was effective to reduce TGM-2 transcripts in the presence of UVB (Figure 
9A). Inhibition of transamidase activity by MDC was effective after UVB (Figure 
9C). 
To investigate whether the UVB induced caspase activation is dependent on 
TGM-2 function, I delivered exogenous (guinea pig liver TGM-2) using a carrier 
system (Appendix) into cultured corneal epithelial cells that had not been exposed to 
UVB. This procedure was verified to increase intracellular cytoplasmic and nuclear 





Figure 9. Effect of delivering exogenous TGM-2. Immunofluorescent staining images. Top: 




Figure 10. Activity of TGM-2 stimulated caspase. A and B. Cell viability assays. 
C and D: Caspase activity assays.
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To address the question of whether TGM-2 stimulated caspase 3 was active, 
experiments were performed to assess caspase activity. Activaiton of caspase may not 
always be associated with caspase activity, since concurrent or parallel signaling may 
also activate caspase inhibitors. In the context of biological functions, caspase activity 
is more important than caspase activation per se, since it is the action of caspase on its 
substrates that determine the apoptotic phenotype. These assays are described in 
Appendix A15. Briefly, the procedure involves culturing cells in 96 well plates. After 
a standard period of incubation, lysis of cells and addition of artificial substrates with 
specificity for caspase subtypes were performed. Luminescence would only be 
emitted when these substrates are cleaved.  
 
The functional outcome of over-expressing full length human TGM-2 in 
cultured cells was investigated by transfecting human corneal epithelial cells (HCE-T) 
with the pSG5 Tgase plasmid (Figure 10). It was found that control cells or cells 
transfected with the humanised GFP plasmid (GFP) proliferated to a greater extent 
(A) and had less non-viable cells (B), especially on day 2 (48 hours after 
transfection).  
The TGM-2 over-expression was associated with an increased caspase-3 and 
caspase-9 activities, but not caspase-8 (Figure 10 C-E). The general caspase inhibitor 
(Z-VAD-fmk), at a concentration of 20 µM, was able to inhibit caspase 3/7 and 9 
activities (C,D) as well as the TGM-2 overexpression stimulated cell death (B). This 
suggests that the TGM-2 related activation of caspase was sufficient to cause cell 
death, given enough time. Z-VAD-fmk inhibitor at 20 µM did not induce 
morphological changes in cultured HCE-T (Appendix B).  
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Caspase 9 activation was associated with the mitochondrial death pathway 
(Liu et al 1996). It is important to determine whether TGM-2 is localised in the 
mitochondria of human corneal epithelial cells and have access to mitochondrial 
proteins. Mitochondrial proteins were extracted from HCE-T (See Appendix for the 
protocol). Western blotting showed that TGM-2 is found within the mitochondrial 
fraction of cells (Figure 11). 
 
Figure 11. Western blot with antibodies against MnSOD a mitochondrial marker, and TGM-2. 
The rat liver mitochondrial fraction was used as a positive control for the extraction procedure, 
as this was used in many other experiments in the laboratory involving mitochondrial proteins. 
 Next, protein extraction from cells over-expressing TGM-2 was performed 
followed by immunoprecipitation with TGM-2 specific antibodies (Appendix A12). 
This was followed by elution, and HPLC separation followed by mass spectrometry. 
Using this method, no low MW elutes was discovered. On the other hand, SDS-
PAGE separation of elutes, silver staining of gel, in-gel tryptic digestion, followed by 
nano-LC, MS/MS (peptide sequencing) proved to be more fruitful. Using this 
procedure 4 mitochondria related peptides were discovered: ATP synthase β chain (57 
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kDa), ATP synthase α chain (59.7 kDa), ADP/ATP translocase 2 (32.7 kDa) and 
ADP/ATP translocase 3 (32.7 kDa). Peptides that match the ATP synthase β chain are 
shown in red in A (Figure 12). In B, a plot shows the fragment ions predicted (vertical 
peaks) and detected (peaks with annotation) corresponding to the ATP synthase β 
chain peptide. Small peaks represent background noise. 
 
Figure 12. Representative mass spectrogram from nano LC MS/MS. 
Immunoprecipitation detected the presence of complexes formed in cell 
lysates. After lysis of cells, the proteins previously sequestered in different sub-
cellular locations can be placed in close proximity. The observed complexes may or 
may not exist in living cells as TGM-2. Other experimental approaches involving 
intact cells are necessary to confirm the TGM-2 interactions. For now, the presence of 
TGM-2 in the mitochondrial fraction of HCE-T suggests that TGM-2 and a 
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mitochondrial protein may possibly interact in living cells as they can be found in the 
mitochondria. 
Why is TGM-2 binding to ATP/ADP translocase? Previous work has found 
that TGM-2 is involved in the mitochondrial ATP production (Szondy et al 2006) and 
that failure of ATP metabolism or energy deprivation may be a possible mechanism 
for loss of mitochondrial membrane potential and initiation of mitochondria mediated 
apoptosis (Tzatsos et al 2007). More research is necessary to determine if such 
mechanisms exist in human corneal epithelial cells, and if so, to ascertain the 
relevance of these processes in ocular surface disease. 
In summary, TGM-2 plays a facilitating role in the apoptosis of human corneal 
epithelial cells. In cells stimulated by UVB, TGM-2 is up-regulated and plays a pro-
apoptotic role that is dependent on caspase. Here, I also show evidence that TGM-2 is 
present in the mitochondria of these cells, and this may have some unknown function 
in the overall enhancement of the apoptosis. Much remain to be clarified in the 
mechanism of TGM-2 related apoptosis. Currently, several experiments are ongoing 
to determine the role of TGM-2 in mitochondrial cell death, involving measurement 
of mitochondrial permeability transition. As in other biological contexts, TGM-2 may 
have more than one role in corneal epithelial cell death. For example, it may have 
other functions such as the crosslinkage of caspases (Yamaguchi et al 2006), or the 
induction of caspase independent cell death in a stimuli specific manner (Tucholski et 
al 2002). In addition, TGM-2 itself may be a target for caspases (Fabbi et al 1999), 
and proteases may be involved in the up-regulation of TGM activity (Chung et al 
1988). In tumors, cell death induced by autophagy was inhibited by TGM-2 (Akar et 
al 2007). 
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Further understanding of these processes in the ocular surface is likely to be a 
rewarding exercise. Topical cyclosporine, arguably the most profitable drug for 
human dry eye has been known to preserve goblet cells by reducing the dry eye-
induced apoptosis in the conjunctival epithelium (Strong et al 2005). The relevance of 
apoptosis in the ocular surface is not restricted to ocular surface epithelial cells. In 
disease like dry eye, the inflammation may be due to defective apoptosis in the 
immune cell infiltrate within the lacrimal glandular tissue (Niederkorn et al 2006). 
Even though TGM-2 is known to be involved in autoimmunity (Szondy et al 2006), 
this aspect is beyond the scope of the thesis. 
Key findings: 
 
• Ultraviolet radiation induced morphological and apoptotic changes in cultured 
human corneal epithelial cells 
• TGM-2 is pro-apoptotic in this form of cell stress 
• UVB induced upregulation of TGM-1 and TGM-2 
• UVB induced cell death in human corneal epithelial cells is caspase dependent 
• TGM-2 is expressed in the mitochondria of human corneal epithelial cells 




CHAPTER V. TRANSGLUTAMINASE AND SIGNALING 
5.1 Transglutaminase and NF-κB signaling 
 
5.1.1 Introduction to NF-κB signaling 
  
The nuclear factor kappa (NF-κ) B is an inflammation related pathway that is 
activated by degradation of the inhibitor of these latent cytoplasmic transcription 
factors (Tergaonkar et al 2002, Tergaonkar et al 2003, Tergaonkar et al 2005). The 
most common member of this family of transcription factors, called the canonical NF-
κB consists of the p65/p50 dimer. When the inhibitor (called the IκBα) becomes 
phosphorylated at a specific site, it forms the target of ubiquitinylation and becomes 
degraded via the proteasome. This allows the translocation of the transcription factor 
into the cell nuclei and subsequent transcription of target genes (Figure 13).  
This UVB-inducible (Lee et al 2005) and viral-inducible (Bitko et al 2004) 
pathway in corneal epithelial cells plays an important role in regulation of cytokine 
expression (Ritchie et al 2004). Furthermore, TGM-2 is involved in the constitutive 
activation of the NF-κB pathway in human malignancies (Chen et al 1999).  
TGM-2 binds to the p65:IкB-α complex in cancer cells, and co-localisation of 
p65 and TGM-2 occurs in the nuclei of tumor cells (Mann et al 2006). In microglial 
cells, TGM-2 transamidates IкB-α and consequently release p65 from its inhibition 




Figure 13. Schematic showing NF-kB activation, 
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Different components of the NF-κB pathway can differentially influence distinct pro-
inflammatory versus differentiation/lymphogenesis-related processes (Tergaonkar 
2006); therefore, selective targeting of the NF-κB pathway may alleviate 
inflammation without hindering vital cellular function and thus minimizing adverse 
effects. If TGM-2 is involved in NF-κB activation, this represents another anti-
inflammatory target for treatment of ocular surface diseases. 
Despite the importance of these considerations, there has been no previous 
study on the role of TGM-2 in NF-κB activation in ocular surface cells. To address 
this issue a few experiments have been performed using the UVB model as well as in 
non-stimulated corneal epithelial cells. 
 
5.1.2 UVB-induced p65 nuclear translocation 
 
UVB induced the p65 cytoplasmic to nuclear translocation in human corneal 
epithelial cells (Figure 14 A-C), agreeing with a previous study (Lee et al 2005). The 
presence of p65 in cell nuclei was detected 1 hour after UVB. Refer to Appendix A6 
for the UVB procedure. This translocation was suppressed by the incubation of cells 
with the TGM inhibitor MDC, as well as a cell permeable peptide inhibitor of p50 
translocation SN-50 (not shown). Incubation with synthetic short interfering (Si) RNA 
reduced the UVB-stimulated translocation of p65. The use of chemicals and 
transfection of SiRNA are describe in Appendices A5 and A4 respectively. 
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Figure 14. UVB stimulated translocation of p65 from cytoplasm to nucleus of human corneal 
epithelial cells in a TGM-2 dependent mechanism. A. Immunofluorescence staining images 
performed in different conditions specified by the header on top. + indicates presence, - indicates 
absence. Primary antibody was specific for p65, and secondary antibody was conjugated to Alexa 
488 (green). MDC: a cell permeable competitive inhibitor of TGM. Si-TGM2: short interfering 
RNA (synthetic oligonucleotides) against TGM2 transcripts. B. Western blot images for the 
nuclear fraction of human corneal epithelial cells, using specific antibody against p65. C. Single 
cell imaging performed after fluorescence microscopy and processing by deconvolution 
algorithm. Green: p65. Blue: DAPI staining for cell nuclei. SiF: non-silencing synthetic 
oligonucleotides used as negative control. D. Guinea pig liver TGM-2 was delivered to human 
corneal epithelial cells using the Chariot peptide carrier. Left column shows control cells with a 
lower level of TGM-2 (green) observed (endogenous TGM-2) as well as a predominantly 
cytoplasmic distribution of p65 (red). Right most image is a merged image of the red and green 
channels. 
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5.1.3 Transglutaminase mediated p65 nuclear translocation  
Over-expression of wild type TGM-2 increased the cytoplasmic to nuclear 
translocation of p65. Using an alternative approach to transfection, guinea pig liver 
TGM-2 was delivered into cultured corneal epithelial cells using a non-covalent 
carrier system (Chariot). This system enabled a dose-dependent increase in the 
detection of TGM-2 using immunofluorescent staining (Figure 9 top). Such a 
procedure increased the translocation of p65 from the cytoplasm to the nucleus 
(Figure 14 D). 
 5.5.4 Transglutaminase mediated NF-κB activation 
Various ligands have been shown to specifically activate the NF-κB activity 
via Toll like receptors in conjunctival cells (Li et al 2007). The secretory alkaline 
phosphatase reporter (pSEAP) assay was used to evaluate NF-κB-dependent 
transcriptional activity (Appendix A13). 
In the absence of TLR ligands, there is a detectable level of NF-κB activity in 
cultured HCE-T cells. In the absence of ligand, TGM2 overexpression was not 
associated with a significant alteration of NF-κB activity (Figure 16A). In order to 
investigate the role of TGM-2 in ligand stimulated NF-κB activity, the palmitoyl-3-
cysteine-serine-lysine-4 (PAM3CSK) peptide, a synthetic peptide that stimulates 
TLR1/2 signaling was employed. This peptide was used at a concentration of 250 
ng/ml and incubated with cells for 16 hours. The ligand stimulated increase in NF-κB 
dependent transcriptional activity was not significantly affected in the presence of 
TGM2 over-expression (Figure 16A). This suggests that TGM2 expression status 
does not affect TLR-ligand induced inflammatory signaling.  
PAMSCSK stimulated a significant rise in the steady state transcript levels of 
monocyte chemoattractant protein (MCP)-1 (Figure 16B), which was suppressed by 
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overexpression of TGM-2.  MCP-1 is an important target gene for the NF-κB 
pathway in human corneal epithelial cells infected by viruses (Bitko et al 2004). In the 
present study, the reason for suppression of MCP-1 by TGM-2 over-expression is 
unclear. Furthermore the suppression of PAM3CSK induced increase in MCP-1 
protein level by TGM-2 over-expression was also detected in the culture media of 
cells using a bead-based sandwich immunofluorescent assay (Luminex 100) in 
preliminary studies (data not shown). Part of the suppressive effect of TGM-2 may be 
related to concurrent inhibitory effects on p38 signaling (Rovin et al 1995), which 
may reduce the amount of AP-1 cotranscriptional factor (Martin et al 1997) at the 
MCP-1 promoter. TNF-α induced NF-κB mediated transcription of MCP-1 is known 
to be regulated by multiple signaling pathways (Goebeler et al 2001), which may also 
apply to PAM3CSK initiated signaling. Whatever the mechanism, this type of 
regulation is worth further investigation since MCP-1 is an important CC chemokine 




Figure 15. Transglutaminase (TGM)-2 and ligand-stimulated NF-êB dependent transcriptional 
activity. A. The pSEAP assay was used to evaluate the PAM3CSK stimulated increase in NF-êB 
dependent transcription. Collection of culture medium was performed at 16 hours after 
stimulation of cells with PAM3CSK. A 96 well chemi-luminescence assay was used for detection 
of alkaline phosphatase. Cells (semi-solid bar) transfected with pSG5 (vector with no insert) were 
compared with cells (empty bar) with over-expression of TGM2 via transfection with pSG5 
Tgase. B. Real time PCR results showing the relative transcript levels of Monocyte 
Chemoattractant Protein-1 calibrated to GADPH transcript levels. PAM3C=PAM3CSK. 
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In summary, TGM-2 may influence the NF-κB pathway in different ways in 
the human corneal epithelial cells, depending on the context. UVB stimulation or 
transfection of corneal epithelial cells with a TGM-2 expressing vector mediated p65 
cytoplasmic to nuclear translocation. However, in the presence of a TLR1/2 ligand, 
the increase in NF-κB activity is not dependent on TGM-2 overexpression status. 
These findings suggest that TGM2 may be involved in certain stress pathways 
induced by UVB but may not be involved in the inflammation associated with 
microbial stress. It is important to note that in clinical infections, there may be a 
concurrent rise of cytosolic calcium after various signaling, which may activate latent 
TGM. The activation of such TGM may or may not affect the NF-κB pathway, as this 
has not been assessed in this study. 
In any form of stimulation of the NF-κB pathway, the p65 that translocated to 
the nuclei after UVB may or may not be active, as activity of p65 may depend on the 
identity of the other partner in the NF-κB dimer, on post-translational changes such as 
phosphorylation, presence of other transcription co-factors, or on accessibility of 
promoter sites.   
Currently electrophoretic mobility gel shift assays are being performed as an 
independent way to evaluate NF-κB activity. More studies are also required to 
determine whether the transamidase function of TGM2 is required for its effect on 
NF-κB. 
A study using UVB stimulation has shown that the cell death in HCE-T is 
mediated by the activation of NF-κB (Lee et al 2005). However, this may not 
necessarily be true in TLR initiated TGM-2 mediated NF-κB pathways, as multiple 
different receptors are stimulated in corneal epithelial cells after UVB (Lu et al 2003). 
Some of the UVB-activated pathways may influence NF-κB to transcribe different 
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target genes from those initiated by TLR signaling. In the culture system used in the 
present experiments, the increase in NF-κB activity stimulated by PAM3CSK4 was 
not associated with significant apoptosis (data not shown). 
The clinical importance of NF- κB extends beyond inflammation.  It is 
interesting that one of the upstream regulators of the NF-κB, the IKK-α, plays a vital 
role in the differentiation of corneal epithelial cells (Yoshida et al 2000). Currently 
the ex-vivo maintenance of limbal-derived ocular surface stems cells is useful for 
transplantation in patients with stem cell deficiency. Understanding of TGM-2-related 
NF-κB pathway may enable technologists to efficiently control cell expansion of 
clonogenic cells and inhibit premature differentiation and lineage commitment during 
cell culture. 
59 
 5.2 Cornified envelope proteins in corneal epithelial cells 
 
5.2.1 Introduction to cornified envelope proteins 
Stratified squamous epithelial cells assemble a specialised protective barrier 
structure on their cell periphery called the cornified cell envelope (Melino et al 1998). 
Skin keratinocytes express loricrin, involucrin, small proline rich proteins (SPRR), 
late-envelope proteins (LEP) and filaggrin. As part of the development of the skin 
epidermis, the cornified envelope precursors become cross-linked to form a 5-10 nm 
mature envelope adjacent to the cell membrane. This transmidation process is 
mediated by TGMs, and occurs sequentially, allowing the classification of precursors 
into early (SPRR and involucrin) or late proteins (LEP and filaggrin). 
The role of cornified envelope proteins in barrier function of the skin has been 
previously reported (Maatta et al 2001, Marshall et al 2001). Unlike the skin, the 
cornea does not have a water-impermeable apical layer. In fact, the nutrition of the 
cornea epithelial cells depend on the tear components bathing the apical cells. On the 
other hand, the tight junctions maintained by the basal corneal epithelial cells are 
crucial for maintenance of barrier so that the corneal stroma remains relatively 
dehydrated. Despite these differences from the skin, normal cornea epithelial cells 
have been known to express involucrin, and ocular surface involucrin and filaggrin 
were known to be greatly elevated in diseases like Steven Johnson syndrome and 
alkaline burns. Increased involucrin and loricrin have also been found in the cornea of 
rats in a dry eye model (Toshino et al 2005).  
Naturally occurring anti-inflammatory cornified envelope proteins such as 
elafin are found to be secreted by cells (Molhuizen et al 1993). Although elafin has 
been detected in human tear fluid (Sathe et al 1998), its expression has not been 
documented in the ocular surface.  
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These findings suggest that cornified envelope proteins may have a regulatory 
role. TGM’s catalytic activity increases in disease states. This increase occurs 
concomitantly with upregulation of cornified envelope proteins, resulting in a 
relatively impermeable, keratinised ocular surface epithelium. Although the type of 
TGM most studied in the context of keratinisation in ocular surface diseases is TGM-
1 (Nishida et al 1999, Nakamura et al 2001), various forms of TGM, including TGM-
2 may function in parallel or sequentially to form the mature cell envelope (Melino et 
al 1998). 
The effect of TGM inhibition on the expression of cornified envelope proteins 
has not been reported in the cornea. To address the above-mentioned issues, a 
descriptive study of cornified envelope proteins in human corneal epithelial cells and 
tissue is performed. As a secondary aim, a cell culture model of barrier function using 
UVB was developed and evaluated, since the major functional disturbance associated 
with cornified envelope proteins dysfunction is increased epithelial permeability.  
5.2.2 Cornified envelope proteins in human corneal cells and tissues 
First, the presence of various types of envelope proteins was demonstrated. 
SPRR1A, 1B, 2A, 2B and 3 transcripts were found to be expressed in cultured corneal 
epithelial cells. In addition, immunofluorescence staining demonstrated the presence 
of SPRR1, SPPR2 as well as involucrin in native corneal epithelial tissue (Figure 16) 
as well as in human corneal epithelial cells (Figure 17). 
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Figure 16. Immunofluorescence staining images showing cornified envelope proteins (green) and 
propidium iodide (PI) staining of the nuclei in the human ocular surface tissue. The primary 
antibodies against the small proline rich proteins (SPRR) 1 and 2, and filaggrin and involucrin 
were used in these experiments. The negative controls were shown in the lowest row. The first 
and second columns show staining in the central and peripheral corneas respectively, whereas 
the third column shows the limbal tissue. 
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Figure 17. Cornified envelope proteins in human corneal epithelial cells. A. Immunofluorescent 
staining images (green) showing the presence of cornified envelope proteins in cultured primary 
human corneal epithelial cells grown from limbal explants. B. Western blot images showing the 
cornified envelope proteins in these cells, C. Hematoxylin and eosin staining image showing 
stratification of the primary human corneal epithelial cells grown on porcine corneal stroma. D 
and E. Immunofluorescent staining images of these composite tissues (green) and nuclei stained 
red by propidium iodide (PI). 
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UVB has already been used previously as a model of wound healing in the 
skin, where changes in the cornified envelope proteins SPRR1, 3 and 4, loricrin and 
filaggrin were detected (Bernerd et al 1997, Del Bino et al 2004). Other models of 
wound healing and barrier function in mouse have also employed the use of 
ultraviolet radiation (Haratake et al 1997, Kambayashi et al 2001, Thiele et al 2003). 
For these reasons, the UVB model (Appendix A6) is employed to investigate the 
stress-induced changes in cornified envelope proteins. 
UVB was found to downregulate some cornified envelope proteins (Figure 
18). MDC a cell permeable inhibitor of TGM, was found to suppress the UVB-
induced changes in the cornified envelope proteins. Furthermore, MDC also partially 
prevented the deterioration of barrier function after UVB. 
What is the relevance of cornified envelope proteins in the human ocular 
surface? The barrier requirements for the corneal epithelium are different from those 
of the skin epithelium. In the skin, cross-bridging envelope proteins strengthen the 
biomechanical properties (Steinert et al 1998a, Steinert et al 1998b). Oxygen and 
nutrients need to permeate the corneal epithelial layers from the tear film. It is 
possible that cornified envelope proteins have evolved away from a purely 
mechanical role in tissues such as the ocular surface. For example, the small proline 
rich proteins may be involved in the innate immunity (Hooper et al 2001, Mueller et 
al 2003), or protection against ischemic stress (Pradervand et al 2004). 
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Figure 18. Semi-quantitative reverse transcription PCR showing transcript levels for various 
cornified envelope proteins. 
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How does TGM interact with cornified envelope proteins? This may occur 
directly or indirectly.  
The most direct interaction is probably the role of cornified envelope proteins 
as transmidase substrates. In disease states the cornified envelope proteins may be up-
regulated and excessively cross-linked in the process of keratinisation, as discussed in 
Chapter 5.2.1. In the skin, hyperkeratosis is believed to be protective (Ajani et al 
2007). In the corneal epithelium, this may be maladaptive, as excessive keratinisation 
destroys the transparency of this tissue, as well as its transport requirements. Such 
transamidation reactions may require the movement of the substrate to the vicinity of 
the enzyme as a prerequisite. For example, involucrin needs to translocate to the cell 
periphery where TGM-1 is anchored (Phillips et al 1993). The cross-linking of 
cornified envelope proteins in-vivo may depend on factors other than the number of 
the available glutamine residues in the substrate (Lambert et al 2000). Apart from 
forming an SDS insoluble envelope, cornified envelope proteins such as filaggrin may 
have other non-covalent interactions with other cytoskeletal proteins (Mack et al 
1993). 
Indirect effects may include the alteration of transcriptional complexes at the 
promoters, such as the promoters of SPRR1A (Pradervand et al 2004) by 
inflammation and stress pathways modulated by TGM-2. 
Are there any differences in the affinity of different TGMs for cornified 
envelope proteins? The relative positions of residues in the substrate binding site are 
highly conserved in different TGM enzymes. However, the charge distribution differs 
among different TGMs and may account for different substrate preferences and 
specialised functions (Esposito et al 2005).  
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In-vivo, most types of TGM can cross-link cornified envelope proteins, but the 
formation of a protective impermeable layer of barrier in epidermal tissue is generally 
attributed to TGM-1 (Greenberg et al 1991). In fact, knocking out the TGM-1 gene is 
lethal due to dehydration, but ablation of TGM-2 does not cause any gross detrimental 
effects in mice (Segre 2003). Interestingly, the cross-linking activity of TGM-1 can be 
found even in the junctional complexes of simple, non-stratified epithelial cells in the 
body (Hiiragi et al 1999, Baumgartner et al 2004).  
There are differences in the sub-cellular distribution of TGM. TGM 
localisation within cells may be influenced by presence of other molecules such as 
collagen (Juprelle-Soret et al 1988). TGM-1 and TGM-3 have different propensities 
for different parts of the SPRR2 protein, and TGM-3 may be responsible for the initial 
oligomerisation whereas TGM-1, the incorporation of oligomers into the cornified 
envelope (Candi et al 1999). In that study, it was noted that TGM-2 had poor affinity 
for the SPRR2 protein. 
Another intriguing question remains: in the corneal epithelium, is there an 
equivalent process to cornification like in the skin epidermis? If so, it may be 
necessary to understand the role of cornified envelope proteins in this process. In the 
skin, this process of cornification is a highly specialised form of programmed cell 
death (Mack et al 2005).  
Certain other components of the cornified envelope, such as the S100 proteins 
(Robinson et al 1997) have not been evaluated. These proteins are detected in human 
tears, and may be relevant as biomarkers of ocular surface inflammation (Zhou et al 
2006). The possible presence of other envelope proteins such as SKALP/elafin, which 
have anti-elastase and anti-inflammatory properties (Molhuizen et al 1993), were also 
not investigated. This cornified envelope protein is known to be involved in chronic 
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human diseases such as psoriasis (Iizuka et al 2004), and is also the basis for the use 
of peptide inhibitors in an animal model of allergic conjunctivitis (Sohn et al 2003), 
an inflammatory ocular surface disease. 
5.2.3 Cell culture model of barrier function 
The experimental procedure for this section is described in Appendix A15. 
Briefly, a monolayer of HCE-T cells is cultured. After aspiration of culture medium, 
UVB was applied at 20 mJ/cm2 to the just confluent cells, the medium was replaced, 
and the cells incubated. For control cells, the medium was extracted and replaced 
without any UVB exposure. After different periods of time, the trans-epithelial 
electrical resistance (TER) was measured. The mean of 3 readings per well over 
different meridia were obtained at each time point, by varying the placement of the 
electrodes. It was found that at this dose of UVB, the TER was significantly reduced 
at 24 hours (Figure 19). Pre-incubation of cells with monodansyl cadaverine (MDC), 
a cell permeable inhibitor of TGM, however, suppressed the UVB stimulated 
reduction in the TER. 
The TER values at 24 hours were inversely correlated to the concentration of 
the 10 kD dextran Alexa 488 conjugates that passed through the cell layer (r = -
0.756). The lower the TER, the greater was the concentration of the dextran Alexa 
488 conjugates that passed through the cell layer. 
This model of UVB stimulation of HCE-T may be useful for functional 
assessment of barrier function. The biological mechanisms that explain the alteration 
of TER may be multiple. For example, part of the change in TER may be due to an 
alteration in the density of the cells. If there was increased cell death after UVB, a 
greater area of the Transwell insert may be exposed. In addition, water and solute 
transport may be affected by subtle changes in tight junction complexes (paracellular 
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transport) or alteration in the membrane permeability (transcellular transport). 
Whatever the biological processes that determine changes in TER, it is useful to 
assess barrier function as a functional outcome using this convenient procedure in the 
laboratory. In the corneal epithelium, barrier function is very important because 
increased permeability leads to corneal stroma edema, reduced transparency and 
visual impairment. The use of this model is potentially useful in the assessment of 





Figure 19. Barchart showing the Transepithelial electrical resistance (TER) readings measured 
in cultured HCE-T cells before and after UVB stimulation. 
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5.3 Phospholipase D in the human ocular surface 
5.3.1 Introduction to phospholipase D 
Phospholipase D (PL) is an important class of enzymes in intracellular lipid 
metabolism. These enzymes act on phosphatidylcholine, the predominant lipids in cell 
membranes. The reaction products include phosphatidic acid and other downstream 
lipids, these products can be secreted to the extracellular environment to act as first 
messengers. Stimulation of 7-transmembrane receptors by these first messengers can 
be a potent source of inflammatory drive. Furthermore, in the context of ocular 
surface diseases, the entire ocular surface epithelium is exposed to pro-inflammatory 
lipids in the tears, such as those from aberrant metabolism of Meibomian gland 
derived lipids. Despite these concerns, the expression and regulation of PLD in 
human ocular surface epithelial tissue have not been described. 
 
5.3.2 Phospholipase D in corneal cells and tissues 
 
PLD expression in native corneal tissues has not been evaluated, but the 
activation of PLD in human corneal epithelial cells (Mazie et al 2006), immortalised 
rabbit corneal epithelial cells (Zhang et al 1998), as well as bovine corneal epithelial 
cells (Akhtar et al 1992, Akhtar et al 1994), has been reported. First, it was 
demonstrated that PLD1,2,3 and 4 RNA were present in native conjunctiva and 
pterygium tissue and that antibody against PLD1/2 were able to detect these proteins 
using Western blots and immunofluorescent staining of the tissue (data not shown).  
In Chapter III, the relevance of TGM-2 in wound healing and the role of 
wound healing in pathogenesis of diseases like pterygium have been explored. Please 
refer to Chapter 3.1 for a description of pterygium as a disease of the ocular surface. 
PLD has been known to play a role in corneal epithelial cell migration, and therefore 
wound healing (Mazie et al 2006). The microarray data (Chapter III) have shown 
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differential TGM-2 and PLD transcript regulation in pterygium. Therefore, I speculate 
that TGM-2 function may also influence PLD. Real time PCR results in human 
corneal epithelial cells over-expressing the TGM-2 show increased steady state levels 
of PLD3 transcripts (Figure 20). One of the mysteries in pterygium is that the 
fibrovascular proliferation progresses in a centripetal fashion, from the conjunctiva to 
towards the central cornea. This process is clinically significant, because it can result 
in visual problems such as astigmatism, tear film disturbances and occlusion of visual 
axis. Since PLD plays a known role in cell migration (Mazie et al 2006), it may also 
play a role in the horizontal migration of pterygium tissue.  
As mentioned above, PLD activity generates lipid metabolites. It is interesting 
that abnormal lipids have been found in pterygium (Peiretti et al 2006). Increased 
intracellular cholesterol metabolism was observed in fibroblasts obtained from four 
patients with pterygium, which was found to be associated with increased 
proliferation of these fibroblasts. 
Future studies are required to determine how TGM-2 increased the PLD3 
transcripts. This issue has clinical relevance, because manipulation of TGM-2 





Figure 20. PLD3 transcript levels using real time PCR in human corneal epithelial cells. 
Control: untransfected cells. GFP: cells transfected with phrGPP II N plasmid, which expressed 
humanised green fluorescent protein. TNF-a: cells treated with recombinant human TNF-a 
cytokine. TGM-2: cells transfected with pSG5 Tgase which over-expressed human TGM-2. 
ShRNA: Cells treated with pSM2 TGM-2 plasmid which expressed a short hair pin RNA which 
specifically silenced TGM-2 transcripts after processing within cultured cells. 
Key findings: 
• Ultraviolet radiation induced activation of the nuclear factor kappa B pathway 
in human corneal epithelial cells 
• Inhibition of TGM reduced the UVB induced activation of the NF-κB pathway 
• Cornified envelope proteins (for example, the SPRR1, 2, filaggrin and 
involucrin, substrates of TGM, are expressed in human corneal epithelial 
tissue 
• UVB regulates the expression of cornified envelope proteins in a TGM 
dependent way, and this is related to stress induced loss of barrier function 
• Several forms of PLD transcripts are upregulated in pterygium 
• TGM-2 over-expression is associated with up-regulation of PLD3 transcripts 
in cultured cells 
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CHAPTER VI. DISCUSSION 
6.1 Summary of findings  
TGM-2 is a protein expressed in human corneal epithelial cells, and TGM-2 
transcripts and protein are up-regulated when stressed by UVB stimulation. The 
increase in TGM-2 expression is associated with apoptosis, and is accompanied by 
increased transamidation of substrates. TGM-2 is down-regulated in pterygium, where 
it may play a role in aberrant wound healing. Global gene expression profiling in 
human corneal epithelial cells suggests that TGM-2 plays a role in regulation of 
structural proteins and regulation of post-transcriptional processing. Expression of 
TGM-2 occurs in cellular compartments of cytoplasm, nucleus and the mitochondria. 
TGM-2 may interact with mitochondrial ATP synthase as well as the ADP/ATP 
translocase. Stimulation of human corneal epithelial cells that increase TGM activity 
may also induce nuclear translocation of p65, the active subunit of NF-κB. TGM-2 is 
also related to barrier function and regulation of lipid mediators such as 
phospholipase D.  
6.2 Limitations 
There are some major limitations to some of the experiments. Firstly, one 
must exercise caution when interpreting results of cell culture experiments. There 
may be several shortcomings to this approach, for example, the inability to study cell-
matrix interactions, epithelial-mesenchymal interactions and epithelial immune cell 
interactions, all of which may play a major role in pathology. Many experiments have 
been performed on a corneal epithelial cell line, which may possess characteristics 
that differ from native cells. One must however remember the advantages of using a 
cell line. This allows larger volumes of cells to be used in optimisation and 
experimentation, which is critical for certain experiments, for example, purifying the 
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mitochondrial proteins. Other advantages include the uniformity of biological 
response, the efficiency of passaging and transfection, etc. 
Secondly, the implications of many of the experimental findings remain 
unclear. The use of pathway information for analysis of gene expression data is a 
relatively new approach and may require more time for validation before it is fully 
accepted by the scientific community. Similarly, an exon based GeneChip array is a 
relatively new tool. The possible utility of this technique includes an analysis of 
alternative splicing of genes stimulated by TGM-2. Such analysis has not been 
rigorously validated by the scientific community. Despite the possible involvement of 
the mitochondria, the mechanism of TGM-2 in the regulation of apoptosis in human 
corneal epithelial cells remains elusive. 
TGM-2 stimulated the cytoplasmic to nuclear translocation of p65, but TGM-2 
by itself may not be sufficient to activate this pathway. In fact, much of the role of 
TGM in the NF-κB pathway is still unclear. It is also unclear whether this pathway 
affects the apoptosis in human corneal epithelial cells. 
The study on cornified envelope proteins is clearly not exhaustive. Some 
proteins such as NICE and envoplakin have not been included. It is unclear if hyper-
keratinisation is attributed to increased TGM-1 function or increase in cornified 
envelope proteins. It is also unclear if some cornified envelope proteins play a bigger 
role than others in ocular surface disease. 
TGM-2’s transamidase functions may overlap with other TGM such as TGM-
1 and TGM-3. The extent of functional redundance is unclear in the context of human 
ocular surface. Barrier function is certainly impaired in the ocular surface during 
pathology. It is still unclear to what extent each type of TGM contribute to the 
maintenance of normal barrier function. 
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6.3 Clinical applications 
Without any doubt, the major findings in this thesis suggest that TGM-2 plays 
a major role in ocular surface diseases, especially in pterygium, and deserves further 
investigation as a potential therapeutic target. Ocular inflammatory diseases where 
this may be relevant include pterygium, dry eye, allergic conjunctivitis and possibly 
other cicatrizing conjunctivitis. In many cases, TGM-2 related strategies may be used 
in addition to conventional therapy, or as an adjunctive therapy. 
Various types of TGM inhibitors have been developed, including 3-halo-4,5-
dihydroisoxazoles, LDN-27219 and KCC009. In fact, development of new and better 
inhibitors to TGM is an active area of research. In order to address deficiency of 
TGM-2, approaches may be either by increasing TGM-2 activity by using an 
appropriate stimulus, for example, a signal that increases cytosolic calcium, or more 
specifically, by over-expression of TGM-2 using a cDNA plasmid delivered to the 
cells. Some plasmids may be delivered using an appropriate system in a topical 
eyedrop formulation. Since certain ocular surface diseases like the pterygium is very 
localised, there is also the possibility of injecting the necessary agent directly into the 
lesion. 
What is more challenging is to decide if TGM-2 function is beneficial in a 
specific clinical context. In laboratory cell culture settings, the effect of TGM-2 in 
inflammation appears to be highly dependent on the nature of the stimulus and the 
endpoint of the measurement that is an indicator of inflammation. In clinical scenarios 
however, inflammation is much more complex and involves the orchestration of 
different tissues, matrix, and the involvement of the immune cells. The lack of an 
animal model of pterygium will impede the understanding of inflammatory factors in 
pterygium. From the standpoint of inflammation, TGM-2 may play a different role in 
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different ocular surface diseases such as microbial infection and pterygium. Further 
more, the role of TGM-2 may change according to the stage of the disease.  
In early inflammation, TGM-2 may promote corneal epithelial cell death, 
reducing barrier function of the epithelium, and encourage pro-inflammatory 
intermediates from the human film to penetrate into corneal stroma. In the context of 
late inflammation, relatively high levels of TGM-2 may be an advantage since this 
cross-links intracellular antigens and prevent their leakage into the surrounding matrix 
thereby reducing further inflammation. In clinical scenarios, it may be desirable in 
early ocular surface disease to inhibit TGM-2, but to allow the increase in TGM-2 
activity in later stages of the disease in order to control the inflammation. 
In the conjunctiva, modulation of wound healing and fibrotic response using a 
TGM-2 directed strategy may improve the success rate of glaucoma surgery. 
 
6.4 Future studies 
In the future, the role of TGM-2 should be explored in animal models beyond 
the allergic conjunctivitis model (Sohn et al 2003). Various compounds that inhibit 
TGM-2 should be evaluated for their efficacy and safety in ocular surface cells. These 
may be screened in a high throughput fashion in multi well plates containing cultured 
cells. One can start with peptides that have been evaluated previously (Sohn et al 
2003), or use maximally diversified small molecule and peptide libraries. 
The mechanism of TGM-2 in various processes should be probed in greater 
depth. For example, the role of TGM-2 in the mitochondria of human corneal 
epithelial cells, the role of TGM-2 in maintenance of mitochondrial potential in these 
cells, and the role of TGM-2 in the NF-κB pathway. Greater understanding of these 
pathways will facilitate combinatorial strategies for inhibition of apoptosis or 
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protection against loss of barrier function. These aspects may be key to the successful 
anti-inflammatory treatment of ocular surface diseases in the next decade. 
The modulation of extracellular matrix by TGM-2 may extend beyond wound 
healing and inflammation. In the sclera, fibroblasts elaborating collagen and other 
matrix components express TGM-2; and TGM-2 RNA and protein levels may be 
suppressed by muscarinic antagonists (unpublished data). Since muscarinic 
antagonists oppose the development of axial myopia by remodelling of the sclera, 
inhibition of TGM-2 may have a potential therapeutic role in myopia. 
Follow up Studies: 
 
• Comparison of wound healing (cell adhesion and migration) in TGM-2 knock 
out and wild type mice 
• Compare the mitochondrial depolarisation and ATP production in cells with 
TGM-2 silencing and over-expression 
• Use of scratch tests to evaluate the production of MMP as a cell culture model 
of pterygium 
• Evaluate the G protein vs transamidase dependent activity of TGM-2 in cell 
death and cytokine production. This will utilise the expression of mutant 
C277S TGM-2 compared to the expression of wild type TGM-2 
• Evaluate the efficacy of a synthetic peptide TGM inhibitor in cultured cells 
and any alteration of cell phenotype and cytokine production after cell stress 
• Investigate the epigenetic silencing of TGM-2 gene by comparing the extent 
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CHAPTER VIII. APPENDICES 
Appendix A: List of laboratory techniques 
 
1. Cell culture 
primary corneal epithelial cells  
T-HCEC  
Culture medium 
Culture conditions  
Types of culture dishes 
 
2. Preparation of tissue  
for explant culture 
for staining (frozen sections) 
for electron microscopy 
 
3. Preparation of plasmids 
Making LB broth and agar 
Cloning using E cloni bacteria 
DNA extraction, purification, and quantification 
Restriction digests 
 





5. Use of chemical inhibitors, exogenous protein and cytokines 
TGM inhibitor 
NF-κB inhibitor (IKK and p65)   
TNF-RI antagonist 




6. Ultraviolet radiation procedure 
 
7. Cell Lysis 
Extraction of RNA and quantification 








Phase contrast light microscopy 
fluorescence microscopy (direct and inverted) 





Immunocyto- and histo-chemistry  
Immunofluorescent staining 
 









13. Reporter assays 
 
14. Polymerase chain reaction 
Reverse transcription 
Semi-quantitative PCR 
Real time PCR 
 
15. Functional assays 
MTT cell proliferation assay 
Fluorescein cadaverine uptake (in cells and in lysates) 




16. Gel shift assay 
 
17. GeneChip Microarray 
 
18. Others 
Documentation of nuclear morphology 
 
Appendix B: Antibodies 
 
 
Appendix C: PCR primers 
Appnedix D: Related publications 
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1. Cell culture 
Primary corneal epithelial cells  
Cell culture dishes, plates, centrifuge tubes and other plastic ware were purchased 
from Becton Dickinson (Lincoln Park, NJ, USA). Dulbecco modified Eagle 
medium (DMEM), Ham F-12, keratinocyte-SFM (#10724-011), amphotericin B, 
gentamicin and 0·25% trypsin/0·03% EDTA solution were from Invitrogen-
GIBCO BRL (Grand Island, NY, USA). Fetal bovine serum (FBS) was from 
Hyclone (Logan, UT, USA). Bovine insulin, hydrocortisone, human epidermal 
growth factor (EGF), cholera toxin A subunit, human transferrin, sodium selenite, 
dimethyl sulfoxide (DMSO) were from Sigma (St Louis, MO, USA). 
Primary corneal epithelial cells refer to cells harvested from human cadaveric 
donor tissue directly. This could be done by scraping cells off the limbus ring, or 
by culturing cells emerging from a piece of limbal explant. The preparation of 
tissue for explant cultures will be described in appendix 2 (Preparation of tissue).  
T-HCEC  
This is an SV40-immortalised human corneal epithelial cell line, provided by 
courtesy of Dr K Araki-Sasaki, Kinki Central Hospital, Hyogo, Japan. This cell 
line was transformed by Dr Araki-Sasaki using a recombinant SV40-adenovirus 
vector, with cells originating from a relatively young donor of 48 years old. 
Investigation of this cell line showed that it possesses well developed desmosomes 
at the intracellular junctions, and expression of the large T antigen in the nucleus 
of every cell at any generation. In this thesis, this cell line will be referred to as T-
HCEC. Studies will employ passages 50-60. This cell type can be grown in serum 
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containing medium (referred to as SV-40 medium), or in serum free KSFM 
medium. Please see next section for the composition of different culture media. 
Culture medium 
Insulin, transferring and selenium were purchased in the form of ITS (Sigma, cat 
I3146). Media were generally prepared in 500 mL bottles, shaken and stored at 4 
degrees C. Media were warmed to 37 degrees C before use. All media were 
prepared under sterile conditions (in culture hood) and kept for a period of less 
than 1 month.  
The following table shows the composition of the three types of media used as 
well as the final concentration of the added components. Keratinocyte-SFM (not 
shown in the table) was prepared with the same concentration of added antibiotics 
as the ‘SV40’ medium without the addition of serum. 
In general, corneal derived fibroblasts were grown in ‘fibroblast’ medium, 
primary corneal epithelial cells (grown from explants or scraped from cornea 
limbus) were grown in SHEM medium, T-HCECs were grown in SV40 medium. 
Keratinocyte-SFM was used only prior to experiments where cells separation was 
crucial for efficient transfection, for example with siRNA, or for 
immunofluorescence staining where overlapping cells will interfere with the 
quality of the final images.  
Primary corneal epithelial cells grown in SHEM have been well characterized by 
previous investigators from the same laboratory. In my experience, the main 
difference in morphology for the cells grown in keratinocyte-SFM is that the cells 
possess longer cytoplasmic processes and are less rounded. They also adhere to 
each other relatively less. In serum containing media, isolated attached T-HCEC 
grows quickly in clumps. 
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 SHEM  SV40 Fibroblast 
DMEM 50% by volume 50% by volume 100% by volume 
F12 50% by volume 50% by volume  
Gentamicin 50 µg / ml 50 µg / ml 50 µg / ml 
Amphotericin B 1.25 µg / ml 1.25 µg / ml 1.25 µg / ml 
Insulin 5 µg / ml   
Transferrin 5 µg / ml   
Selenium 5 ng / ml   
DMSO 0.5% by volume 0.5% by volume  
Hydrocortisone 0.5 µg / ml   
EGF 5 ng / ml   
Cholera Toxin A 30 ng / ml   
FBS 5% by volume 10 % by volume 10 % by volume 
 
Culture conditions  
This section describes the culture conditions of established cultures after the initial 
seeding. Refer to the next section for the procedure used in the initial seeding of 
primary corneal epithelial cells. 
Cells were generally incubated in a culture incubator at a temperature of 37 
degrees C, a carbon dioxide concentration of 5% and humidity of 95%. Cell 
culture incubators were checked weekly and cleaned on a monthly basis.  Culture 
media were replaced with fresh media every 2 days. 
T-HCEC proliferates very quickly, and a confluent 10 cm culture dish with T-
HCEC usually contains 4-6 million cells. Confluent cells are either passaged or 
frozen and stored. When 700 000 T-HCECs are seeded onto a 10 cm culture dish, 
confluency can be achieved in about 5 days. In general, cells used in experiments 
were seeded at an appropriate concentration overnight prior to the experiment. 
The exception to this rule was in the case of TER measurements for cells seeded 
within culture inserts, where cells were seeded 5 days prior to experiments. 
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In general, primary corneal epithelial cells grow and proliferate slower relative to 
T-HCEC under the above conditions. Primary cells grown for 7-12 days with 50-
70% confluency were designated ‘young’ cell cultures. Cells grown to 70-99% 
confluency, usually grown for 13-17 days, were designated ‘sub-confluent’, 
whereas cells grown for 18-21 days and noted to be 100% confluent were labeled 
‘confluent cells’. ‘Older’ cells referred to cells that were over-confluent, grown 
for more than 21 days and noted to have a relatively more opaque appearance. 
Procedure for passaging, freezing and thawing cells 
Trypsin-EDTA 0.25% (# 25200-056) and trypsin-EDTA 0.05% (#25300-054) 
were obtained from Invitrogen-GIBCO BRL (Grand Island, NY, USA). Nalgene 
cryo 1 deg C freezing container  (#5100-0001) was purchased from Nalge Nunc 
International, Rochester, NY. 
Cells to be passaged were washed in sterile phosphate buffered saline (PBS) 
twice. 
Trypsin was warmed to 37 degrees C before use. Trypsin 0.25% was used to 
detach and separate primary corneal epithelial cells, whereas trypsin 0.05% was 
used for T-HCEC. In general, the volume of trypsin used was half the volume of 
the culture medium per well, except in the case of 10 cm dishes, 3 ml of trypsin is 
usually sufficient. After the addition of trypsin, cells were re-incubated for 5 or 10 
minutes in the case of trypsin 0.25% or 0.05% respectively. For the case of T-
HCEC, an incubation of 10-15 minutes may be required before all cells separated 
from the culture dish. In general, the complete separation of T-HCECs from the 
dish could be verified by direct visualization and aided by gentle rocking motion. 
After this step, ‘fibroblast’ medium containing 10% serum was added to each 
well, and at least the same volume of medium as the trypsin used. Centrifugation 
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of this cell containing mixture was then performed after transferring to a 50 ml 
sterile tube and capped. Centrifugation was performed for 5 min at 700-1000 g. 
After aspiration of the supernatant, cells would be re-suspended in 1-2 ml of the 
appropriate medium. A 10 µL sample was then aspirated from each 50 ml tube 
and viable cells counted using a hemocytometer using the tryphan blue exclusion 
method. Adequate mixing prevented clumping of cells. Cells clumped together 
during the counting process would be counted as a single cell. After establishing 
the concentration of the cells, more medium would be added to reach the desired 
concentration for seeding into fresh sterile culture dishes. 
A mixture of 90% FBS and 10% DMSO was added to cells to be frozen. At least 
one million cells were added to a capped sterile tube. Up to 18 tubes were added 
to each of the Nalgene freezing container with contains 250 ml of alcohol, and 
placed at a temperature of -80 deg C overnight. Subsequently, the cells would be 
transferred out of the freezing container into a cardboard box into a liquid nitrogen 
chamber. 
Cells to be thawed were quickly removed from liquid nitrogen and immersed in a 
sterile solution pre-warmed to 37 degrees C. After complete thawing, the cells 
were spun down using the centrifuge settings as for passaging. After aspiration of 
the supernatant, fresh culture media were added to re-suspend cells and then these 
were incubated as usual. 
Types of culture dishes 
The following types of culture containers were used: 12-well plates, 6-well plates, 
12 well Transwell plates containing inserts with pore size of 0.4 micrometers 
diameter (3460, Corning Inc, Corning, NY), 12 well plates lined with Secureslip 
coverslips, and 8 well chamber slides. 
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The following table shows the volume of culture medium used and the number of 










Inserts on 12 
well plates 










6 X 105 2-3 X 105 4 X 104 2 X 104 2 X 104 
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2. Preparation of tissue  
Preparation of limbus for explant culture 
Corneoscleral tissues were rinsed with Hank’s balanced solution containing 50 
µg/ml gentamicin and 1·25 µg/ml amphotericin B. After carefully removing the 
central cornea, excess sclera, iris, corneal endothelium, conjunctiva and Tenon’s 
capsule, the remaining limbal rim was cut into 12 equal pieces (about 2 X 2 mm2 
size each). Two pieces with their epithelium side up were directly placed into a 
well of 6 well-culture plate or into a 35-mm dish, and they were covered with a 
drop of FBS overnight. The explants were then cultured in SHEM medium 
Preparation of tissue for staining (frozen sections) 
OCT compound was obtained from Sakura Finetek USA Inc., Torrance, CA, USA 
whereas Immu-Mount was from Thermo-Shandon; Pittsburgh, PA, USA. 
Optisole-GS was purchased from Bausch and Lomb Inc, Rochester, NY, USA. 
Anti-fade Gel/Mount (M01) was from Biomeda Corp, Foster City, CA, USA. 
Fresh human corneal tissues were obtained from the National Disease Research 
Interchange (NDRI; Philadelphia, PA). Details of tissue preparation have been 
described.(Chen et al 2004) Briefly, the specimens were cut and embedded in a 
mixture of 75% OCT and 25% Immu-Mount (by volume) and frozen in liquid 
nitrogen. Frozen sections (6-10 µm thick) were used for immuno-staining. Human 
corneoscleral tissues, which did not meet the criteria for clinical use, from donors 
aged 2–94 years were obtained from the Lions Eye Bank of Texas (Houston, TX, 
USA) for the purpose of limbal explant culture. The details of the donors’ 
condition, tissue procurement and length of preservation were supplied by the Eye 
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Bank. These tissues were preserved in Optisole—GS at 4o C until they were 
processed for culture. 
Preparation of tissue for electron microscopy 
Corneal explant tissue from cadaveric human limbus was prepared and cut as 
previously described.(Kim et al 2004) After UVB irradiation as above, the corneal 
epithelial explants were carefully removed and fixed in 2% glutaraldehyde. They 
were subsequently prepared for transmission electron microscopy as previously 
described.(Chen et al 2004, Strong et al 2005) 
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3. Preparation of plasmids 
Cloning using E cloni® bacteria 
E cloni® chemically competent cells were purchased from Lucigen corp, Middleton, 
WI. (#60106-1). QIAprep® Miniprep was obtained from Qiagen  (#27104, Qiagen 
Inc, Valencia, CA). Plasmids expressing full length TGM-2 and the cysteine 277- 
serine mutant TGM-2 were courtesy of Dr Peter J Davies, University of Texas Health 
Science Center, Houston. A humanized green fluorescent protein expressing reporter 
plasmid: Vitality® phrGFP II-N (#240145) mammalian expression vector was 
obtained from Stratagene, Lo Jolla, CA. 
The pSG5 expressing full length native or the mutant TGM-2, and the phrGFP II-N 
plasmids were propagated before use in experiments. The pSG5 plasmids confer 
ampicillin resistance whereas the phrGFP II-N confer kanamycin resistance. 
E cloni® chemically competent cells are a derivative of E.coli that have been 
optimized for high efficiency transformation by heat shock, producing > 3 X 108 
cfu/µg supercoiled pUC 19 DNA. The transformation procedure was performed as in 
the manufacturer’s instructions. Briefly cells were removed from storage conditions 
of -80 degrees C and completely thawed on ice before use (about 15 minutes). 1-2 ng 
of DNA was added to 40 µL of cells and incubated on ice for 30 minutes. Cells were 
heat shocked by placing them in a 42 degrees C water bath for 45 seconds. The cells 
were then returned to ice for 2 minutes. 960 µL of Recovery Medium provided with 
the competent cells was added and placed in a shaking incubator at 250 rpm for 1 
hour at 37 degrees Celsius.  About 25 µL of the mixture was spread on each agar plate 
and incubated overnight at 37 degrees C. 
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DNA extraction, purification, and quantification 
On the next day, individual transformed clones could be picked with a sterile 
inoculation loop (Bac-loops #1400, CCP Scientific Inc) and immersed into 5 ml of 
LB culture medium containing the appropriate antibiotic. Each 50 ml sterile tube was 
then incubated 6 hours to overnight at 37 deg C. If bacteria growth was detected the 
next day, the media would be cloudy. In which case 800 µL of the mixture would be 
removed and  mixed with an equal volume of 100% glycerol and stored at -80 degrees 
C. DNA extraction was performed on the rest of the cells in the mixture, following 
instructions from the Qiagen kit. Briefly, the bacteria were centrifuged at 3000 g for 
10 minutes at room temperature and re-suspended in RNase A containing buffer P1. 
After addition of buffers P2 and N3, cells were centrifuged for 10 minutes at 17900 g. 
The supernatant was transferred to a spin column and centrifuged. The DNA trapped 
in the column was washed with buffers PB and PE sequentially, and the final elution 
was performed with 50 µL of buffer EB and centrifuging for 1 minute. Using such a 
method, I typically obtain DNA concentrations of 0.1 to 0.35 µg/ µL.  
After extraction and purification, quantification of DNA was performed using UV 
spectrophotometry with the Beckman DU® UV/Vis Spectrophotometer (Beckman 
Coulter Inc, Fullerton, CA). 
Restriction digests 
About 5 µL of the purified DNA was used in restriction digests. Digestion of the 
plasmids with Pvu II was performed in a reaction  mixture with the following 
concentrations Tris-HCl (pH 7.4) 50 mM, MgCl2 6 mM, NaCl 50 mM, and KCl 50 
mM at 37 degrees C for one hour.  Digestion of the TGM-2 expressing pSG5 yielded 
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fragments of lengths 119 and 7226 base pairs. Digestion of phrGFP II-N, on the other 
hand, yielded five fragments of lengths: 873, 1268, 1407, 2382 and 2990 base pairs.  
Making LB broth and agar 
LB broth was made up to 1 litre with the following constituents: 10 g of NaCl, 10 g of 
tryptone, 5 g of yeast extract in deionized water. The pH was adjusted to 7.0 by 
addition of 5 N NaOH and autoclaved. LB broth was stored at room temperature 
except when antibiotics have been added, in which case it was stored at 4 degrees C. 
LB agar (1 litre) was made with the following components: 10 g of NaCl, 10 g of 
tryptone, 5 g of yeast extract, 20 g of agar in deionized water. The pH was adjusted as 
above and the mixture autoclaved. Antibiotics were added after cooling to 55 degrees 
C. About 25 ml of agar was poured into each 10 cm plate. 
Antibiotics kanamycin or ampicillin were added accordingly into LB broth or agar to 
facilitate selection of bacteria, at a final concentration of 50 µg/mL. 
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4. Transfection procedures 
Plasmid transfection 
Transient DNA plasmid transfection was achieved using using one of 2 ways: 
Method 1: 
 jetPEITM (#101-01, Polyplus transfection, San Marcos, CA.) via Bridge Transfection, 
a Bridge Bioscience Corporation, a polyethylenimine (PEI) based transfection 
reagent. 
The PEI cationic polymer is a transfection reagent with significant advantages over 
widely used cationic lipid based polymers. Classically, non-viral methods of 
transfection are considered to be of lower efficiency. Cationic lipids often require 
addition of neutral or amphiphilic lipids to achieve delivery. Lipid or lipopolyamine-
DNA complexes, once endocytosed, requires additional endosomal disrupting agents 
to release the DNA for it to be accessible to the cell’s transcription apparatus. In 
addition, low lipid concentration may allow DNA to escape from the complex and 
permitting only transfection with free DNA. (Remy 98) 
Synthetic PEI, because of its ability to bind DNA and form small globular or toroidal 
complexes, should prevent the premature escape of DNA from the complex. The most 
important advantage is the intrinsic endosomal release activity which is due to ability 
of PEI to serve as a ‘proton sponge’. Within the endosome, the net increase in ionic 
concentration, the swelling of the polymer by internal charge repulsion and water 
entry result in reduction in the half life of the endosome. (Remy 98) 
In various studies, a commercial 25 kDa branched PEI preparation (Sigma Inc) has 
been shown to be highly efficient in a variety of cell lines in serum and serum free 
media and is a stable reagent with a long shelf life. In HEK 293T cells, the efficiency 
of transfection (β-galactosidase reporter) was 90-100%. Using the MTT assay, PEI 
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has been shown to be significantly less toxic than 2 other reagents from Sigma’s 
competitors. (Technical bulletin, E9778) 
Recently, a group has successfully transfected an SV-40 transformed corneal 
epithelial cell line (T-HCEC) with a commercially available PEI system. A full length 
phosphoprotein (pnn) of 140 kDa, tagged with green fluorescein protein (GFP) was 
expressed using a DNA vector construct. Western blot detected the expressed protein 
after sorting GFP positive cells with FACS. The authors however, did not report the 
percentage of GFP positive cells observed. In addition, shRNAi was also successfully 
introduced into these cells. (Joo et al) 
In my studies, PEI was used according to the manufacturer’s instructions. Briefly, 
plasmid DNA was diluted with 150 mM sterile NaCl and jetPEITM was similarly 
diluted in 150 mM NaCl. The diluted jetPEITM was then added to the diluted plasmid 
and after gentle vortexing, incubated at room temperature for 20-30 minutes. The 
DNA-PEI mixture was then added to the cells drop by drop. Incubation was for a 
period of 24 hours in the usual cell culture conditions before further experimental 
procedures. The following table shows the volumes of the various mixtures and the 
amount of DNA and PEI used for the cells cultured in each well of the different 









12 well plate 1 µg 1 µg 50 µL 50 µL 
6 well plate 3 µg 3 µg 100 µL 100 µL 
 
Method 2: 
This method uses the Fugene VI transfection reagent (Roche, Indianapolis, IN, USA). 
This is a lipid based multi-component non-liposomal transfection reagent. The 
procedure adopted was as in the manufacturers instructions. The following table 
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shows the common culture vessels and the ratio of the reagent to the plasmid DNA 
used for transfection per well.   
Type of culture 
vessel 
Starting volume of 
FuGene VI reagent 
(µL) 
Starting mass DNA 
(µg) 
10 cm plate 18 6 
6 well plate 3 1 
12 well plate 1.5 0.5 
 
SiRNA transfection 
RNAifect transfection reagent (#301605) was purchased from Qiagen (Qiagen Inc, 
Valencia, CA).  Silencer® pre-designed siRNA was obtained from Ambion (Ambion 
Inc, Austin, TX). Short interfering (Si) RNA against TGM-2 (ID: 111472) and 
fluorescein-conjugated SiRNA (1022079) were used.  The sense and anti-sense 
sequences (5’ to 3’) of the SiRNA against TGM-2 were 
GGCCCGUUUUCCACUAAGAtt and UCUUAGUGGAAAACGGGCCtt 
respectively. The dsRNA sequence targeting mRNA for TGM2 (accession number in 
GenBank: NM_198951) corresponded to part of exon 3 of the TGM-2 gene. The 
sense and anti-sense sequences (5’ to 3’) of the fluorescein-conjugated SiRNA were 
UUCUCCGAACGUGUCACGUdTdT and UUCUCCGAACGUGUCACGUdTdT 
respectively. Details of SiRNA transfection with the RNAiFect reagent have been 
previously described.(Chen et al 2005) Briefly, the ratio of siRNA to RNAifect used 
was 1:8. The silencing or non-silencing (control fluorescein-conjugated siRNA) 
siRNA (1 µg per well in the case of a single well in a 12 well plate) was applied at a 





ChariotTM protein delivery system was from ActiveMotif, Carlsbad, CA. Guinea pig 
liver transglutaminase was from Sigma (#T5398, Sigma-Aldrich, St Louis, MO). 
SecureslipTM glass coverslips (#70462) were obtained from Electron Microscopy 
Sciences, Hatfield, PA.  
ChariotTM is a transfection reagent that can transport biologically active proteins, 
peptides and antibodies into mammalian cells.(Morris et al 2001) The reagent 
contains a peptide that forms a non-covalent complex with the macromolecule to be 
delivered. Upon introduction to cells, the carrier-macromolecular complex is rapidly 
internalized and dissociated. The carrier peptide is then localized to the nucleus where 
it is degraded. Exogenous transglutaminase was delivered to cultured corneal 
epithelial cells using the ChariotTM system according to manufacturer’s instructions. 
Briefly, diluted ChariotTM reagent was incubated with 1 µg or 0.5 µg of guinea pig 
liver transglutaminase for thirty minutes at room temperature. Subsequently, the 
protein-Chariot complex was added to wells containing cultured corneal epithelial 
cells in a 12 well plate for 1 hour and subsequently replenished with complete serum 
containing media without removing the existing media.  
Further procedures such as immunofluorescence staining, was performed 24 hours 
after incubation of cells with the introduced protein complex. 
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5. Use of chemical inhibitors, exogenous protein and cytokines 
General procedure for the use of inhibitors 
Cell permeable chemical inhibitors were first evaluated over a range of concentrations 
in the cell type to be evaluated. The cells were incubated overnight and evaluated for 
morphological evidence of toxicity, for example, alteration of the normal morphology 
or detachment of cells from the bottom of the dish. In experiments requiring 
intervention such as ultraviolet stimulation, the chemical inhibitor was added 1 hour 
before the irradiation and continued for various time intervals after irradiation. 
TGM inhibitor 
5-dimethylaminonaphthalene-1-(N-(5-aminopentyl) sulfonamide or mono-dansyl 
cadaverine (MDC #D113) and fluorescent cadaverine (#A10466) were from 
Invitrogen-Molecular Probes, Carlsbad, CA. 
NF-κB inhibitor (IKK and p65)   
SN-50 peptide, a cell permeable soluble inhibitor of NF-κB translocation, was 
purchased from Calbiochem (#481480, EMD Biosciences, San Diego, CA). This 
contains the nuclear localization sequence of the transcription factor p50. 
Wedelolactone was also purchased from Calbiochem (#401474). This is an IKK 
inhibitor II a naturally occurring active ingredient from the herbal medicine Eclipta 
alba, that acts as a selective and irreversible inhibitor of IKK kinase α and β activities. 
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TNF-RI antagonist 
This is a monoclonal anti-human TNF RI/TNFRSF1A antibody (MAB225), obtained 
from R and D systems Inc, Minneapolis, MN. This antibody is able to neutralise the 
activity of human TNF RI in a dose dependent way. 
Guinea pig transglutaminase  
Guinea pig liver transglutaminase was from Sigma (#T5398, Sigma-Aldrich, St Louis, 
MO). 
TNF-α 
This is a recombinant human cytokine from R and D systems. 
IFN-γ 
This is a recombinant human cytokine (IF002) obtained from Chemicon, Temecula, 
CA. 
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6. Ultraviolet radiation procedure 
UVB was administered with a UVB lamp (UVM57, UVP, Upland CA, USA) which 
principally emitted medium ultraviolet wavelengths. The power output of the lamp 
was monitored using a UVX radiometer (UVP, Upland CA, USA) and a 302nm 
sensor probe was placed under the UVB source where the irradiated cell cultures 
would be placed.  A single dose of UVB at 20 mJ/cm2 was used to stimulate cells in a 
sterile culture hood, which generally corresponds to 24 seconds of continuous 
exposure after stabilization of power. Culture wells that did not receive any UVB 
exposure were used as controls. The media for all cell cultures (including non-
irradiated controls) were aspirated before the irradiation and replaced immediately 
after the irradiation. 
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7. Cell Lysis 
Before extraction of RNA or proteins from attached cells, culture media were 
aspirated and cells washed gently with PBS twice. 
Extraction of RNA and quantification 
RNA extraction was attempted using 2 methods. After extraction, quantification of 
RNA was performed using UV spectrophotometry with the Beckman DU® UV/Vis 
Spectrophotometer (Beckman Coulter Inc, Fullerton, CA). 
A. Trizol® Method 
Trizol® agent was from Invitrogen-Gibco, Grand Island, NY, USA. 
TRIZOL® Reagent (U.S.Patent No.5,346,994) is a ready-to-use reagent for the 
isolation of total RNA from cells and tissues. The reagent, a mono-phasic solution of 
phenol and guanidine isothiocyanate, is an improvement to the single-step RNA 
isolation method developed by Chomczynski and Sacchi (1). During sample 
homogenization or lysis, TRIZOL Reagent maintains the integrity of the RNA, while 
disrupting cells and dissolving cell components. Addition of chloroform followed by 
centrifugation, separates the solution into an aqueous phase and an organic phase. 
RNA remains exclusively in the aqueous phase. After transfer of the aqueous phase, 
the RNA is recovered by precipitation with isopropyl alcohol. After removal of the 
aqueous phase, the DNA and proteins in the sample can be recovered by sequential 
precipitation (2). Precipitation with ethanol yields DNA from the interphase, and an 
additional precipitation with isopropyl alcohol yields proteins from the organic phase 
(2). Co-purification of the DNA may be useful for normalizing RNA yields from 
sample to sample.  
Steps: 
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Cells were lysed directly in a culture dish by adding 600 µL of TRIZOL Reagent to a 
single well of a 6 well plate, and passing the cell lysate several times through a 
pipette. The amount of TRIZOL® Reagent added is based on the area of the culture 
dish (1 ml per 10 cm2) and not on the number of cells present. An insufficient amount 
of TRIZOL Reagent may result incontamination of the isolated RNA with DNA. 
Unless otherwise stated, the procedure was carried out at 15 to 30°C, and reagents are 
at 15 to 30°C. 
120 µL of chloroform was added per 600 µL of TRIZOL® Reagent. Sample tubes 
were capped securely and shaken vigorously by hand for 30-60 seconds and incubated 
at 15 to 30°C for 5 minutes. The samples were then centrifuged at no more than 
12,000 × g for 15 minutes at 2 to 8°C. Following centrifugation, the mixture 
separated into a lower red, phenol-chloroform phase, an interphase, and a colorless 
upper aqueous phase. RNA would remain exclusively in the aqueous phase. The 
volume of the aqueous phase was noted to be about 60% of the volume of TRIZOL® 
Reagent used for homogenization. 
The aqueous phase was transferred to a fresh tube. RNA was precipitated from the 
aqueous phase by mixing with isopropyl alcohol. 300 µL of isopropyl alcohol per 600 
µL of TRIZOL® Reagent used for the initial homogenization. The samples were 
incubated at 15 to 30°C for 10 minutes and centrifuged at no more than 12,000 × g 
for 10 minutes at 2 to 8°C. The RNA precipitate, often invisible before centrifugation, 
would form a gel-like pellet on the side and bottom of the tube. 
The supernatant was removed and the RNA pellet washed once with 75% ethanol, 
adding at least 600 µL of 75% ethanol per 600 µL of TRIZOL® Reagent used for the 
initial homogenization. The sample was mixed by vortexing and centrifuging at no 
more than 7,500 × g for 5 minutes at 2 to 8°C. 
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At the end of the procedure, the RNA pellet  was air-dried for 5-10 minutes. Partially 
dissolved RNA samples have an A260/280 ratio < 1.6. RNA was re-dissolved in 
RNase-free water by passing the solution a few times through a pipette tip, and 
incubating for 10 minutes at 55 to 60°C.  
B. Qiagen Method 
RNeasy® Mini kit (#74104) was purchased from Qiagen Inc, Valencia, CA, whereas 
2-Mercaptoethanol (M3148) was purchased from Sigma, Sigma-Aldrich, St Louis, 
MO. 
The manufacturer’s instructions were adhered to. All steps were performed at room 
temperature. 350 µL of RLT buffer was added per well of a 6 well plate.  
Prior to this 10 µL beta mercaptoethanol was added to RLT buffer 1ml. 
350 µL (or the same volume as RLT buffer) of 70% ethanol in DEPC water was then 
added and mixed by by pipetting. The mixture was then transferred to an RNeasy 
mini column and centrifuged for 15 s (>10000 rpm). 
The flow through was discarded. 700 µL RW1 was added to the column and 
centrifuge for another 15s (>10000 rpm). The flow through was discarded. 500 µL of 
RPE was added to the column and re-centrifuged for 15s (>10000 rpm). 
After discarding the flow through 500 µL of RPE was again pipetted to the column, 
and centrifuged for 2 min (>10000 rpm). 
After discarding the flow through, the RNA was centrifuged dry for 1 minute. 
This time, after discarding the flow through, the column was placed in a new 1.5 ml 
collection tube. 30 µL of RNase free water was added and RNA collected by 
centrifuging 1 min (>10000 rpm). 
124 
Extraction of protein (various types) and quantification 
Mammalian M-PER® protein extraction kit (#78501) NE-PER® (#78833), Mem-
PER® (#89826) and BCA protein assay kit (#23250) were from Pierce Biotechnology, 
Rockford, IL, USA. Costar® disposable cell scrapers (#3010) were from Corning Inc, 
Corning, NY and complete Mini EDTA-free protease inhibitor cocktail tablets 
(#11836170001) were from Roche Diagnostics, Indianapolis, IN. 
Soluble cellular protein 
300 µL of MPER® lysis buffer was added to a single well of a six well plate. A tablet 
of protease inhibitor was dissolved in 10 mL of lysis buffer before use. A sterile cell 
scrape was used to remove any adherent cells. The cell suspension was then 
transferred to an eppendorf tube and vortexed for 15 minutes. Subsequently, the 
mixture was centrifuged and the supernatant retained for protein concentration assay. 
Cytoplasmic and nuclear proteins 
Cytoplasmic and nuclear proteins were extracted as instructed by manufacturer, using 
the NE-PER kit. Briefly, cells were trypsinised and a serum containing medium added 
(see procedure for passaging cells). The cells were then centrifuged and supernatant 
discarded. Fresh cold PBS was added to the cell pellet. Subsequently, for each tube of 
cell pellet (from a single well of a 6 well plate) was lysed with ice cold 100 µL of 
CER I  and 5.5 µL of CER II buffers. Nuclear protein was extracted with 50 µL of 
NER buffer. Before using the CER I buffer, a single tablet of protease inhibitor was 
added to 10 mL of CER I and dissolved just before using the buffer. 
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Membrane protein 
Extraction of membrane protein was performed as instructed by manufacturer, using 
the Mem-PER kit.  
Pellet or insoluble protein 
After centrifuging the cell lysate in the MPER® reagent, the insoluble pellet was 
retained and not discarded. 50 µL of 1% SDS was added to the pellet and vortexed 
vigorously until the pellet dissolved. 
Mitochondrial protein extraction 
Culture medium was carefully aspirated and cells washed with 1XPBS. Dilute 
extraction buffer A from the Mitochondria isolation kit (MITO-ISO1, Sigma-aldrich, 
St Louis, MO) to 1X with ultrapure water. Add 1 µL of protease inhibitor cocktail 
solution in every 1 mL of 1X Extraction buffer A. 10mL of MSHE buffer was added 
into each T-175 flask, followed by scraping of adherent cells into a cell suspension, 
and transfer of cell suspension into a 50 mL centrifuge tube. Another 5 mL of MSHE 
buffer was used to flush each  flask to maximise the yield of cells, before being 
transferred to a new 50 mL tube. 
After centrifuging down to a pellet 1000 rpm for 5 min at 4°C the supernatant was 
removed. 1.5 mL of fresh MSHE buffer was added to re-suspend pellet. The 1.5 mL 
cell suspension was divided into 2 eppendorf tubes, and spun for 1600 rpm, 5mins, at 
4°C. 400µL of 1x extraction buffer was used to resuspend pellet. Viability of cells 
was checked using trypan blue exclusion (1 volume of cells: 1 volume of trypan blue, 
5µL:5µL) – cells should not be stained blue. 
Cells were lysed by repeatedly syringing up and down a 27G needle (at least twice). 
When the cells were checked under the microscope, more than 80% should then be 
stained blue.  
The lysed cells were centrifuged at 800 g for 3 minutes at 4°C. If pellet was not 
visualised, the centrifuging was repeated again at 1000g, 5mins at 4°C.  
The supernatant was transferred to a new 1.5 mL tube and the pellet discarded. 
(Supernatant was not always clear). The centrifuging was then performed at 11000g, 
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15mins at 4°C. The supernatant (the cytosolic fraction) was transferred to a new 1.5 
mL tube and stored at -80°C. 
The extraction buffer (200 µL) was added to the pellet and spun at 1000g, 5mins at 
4°C. The supernatant was transferred to a new 1.5 mL tube and respun at 11000g for 
15 min at 4°C. After discarding the supernatant, 60µL of 1x extraction buffer was 
added to the pellet, pipetted up and down, and stored at -80°C (the mitochondrial 
fraction). 
MSHE Buffer for mitochondrial isolation 
In 500 ml (pH 7.4) 
 Molecular weight Concentration Amount (g) 
Mannitol 182.2 220 mM 20.042 
Sucrose 342.3 70 mM 11.981 
EGTA 380.4 0.5 mM 0.0951 
HEPES 238.3 2 mM 0.2603 
BSA  0.10% 0.50 
 
BCA protein assay 
This was performed using the manufacturer’s instructions. Briefly, protein solutions 
were diluted 75X in nanopure water before loading into a single well of a 96 well 
plate. Albumin standards provided with the BCA kit were diluted with nanopure 
water into concentrations from 80 µg/mL to 2.5 µg/mL. After addition of 150 µL of 
BCA reagent into 150 µL of diluted standard or protein solution of unknown 
concentration, the reaction was incubated for 2 hours at 37 degrees C. The absorbance 
at 570 nm was read using a 96 well reader (VERSAmaxTM tunable microplate reader, 
Molecular Devices, Sunnyvale, CA). 
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8. Imaging 
Phase contrast light microscopy 
Cell cultures or immunohistochemistry images were obtained using the Nikon TE200 
inverted microscope (Nikon, Garden City, NY). In the case of immunocyto or 
histochemistry slides, mounting gel M02 was used (Biomeda Corporation, Foster 
City, CA). 
Fluorescence microscopy (direct and inverted) 
After completion of immunofluorescent staining procedure, a cover slip was applied 
with anti-fade mounting gel M01 (Biomeda Corporation, Foster City, CA). 
Staining patterns were examined and photographed with a Nikon Eclipse 400 epi-
fluorescent microscope with a DMX 1200 digital camera (Nikon, Garden City, NY). 
Image acquisition was performed using the Nikon ACT-1 Version 2.12 software 
(Nikon, Melville, NY). Alternatively, the Nikon TE200 inverted microscope was used 
to image cell cultures in 6, 12 well or larger plates, with the same software. 
Laser scanning confocal microscopy  
22 X 22 mm (#72198-10) or 22 X 40 mm (#72198-20) Esco microscope coverglass 
slides were obtained from Erie Scientific Company, Portsmouth, NH. 
After completion of immunofluorescent staining, a No. ‘0’ thickness glass cover slip 
was applied with anti-fade mounting gel M01 (Biomeda Corporation, Foster City, 
CA). 
Laser-scanning confocal microscopy was performed using a Zeiss microscope (LSM 
510, Zeiss, Thornwood, NY) with Krypton-argon and He-Ne lasers, 488- and 543-nm 
excitation and emission filters, LP505 and LP560, respectively. Images were acquired 
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with × 40 oil-immersion objective and 10X eyepiece objective and processed using 
Zeiss LSM-PC software and Adobe Photoshop 6.0. 
De-convolution microscopy 
For this purpose, cells were seeded on poly-D-lysine coated coverslips for 24 hours 
before any treatment or experimental procedure. Before immunofluorescent staining, 
cells were fixed in 4% formaldehyde and quenched with ammonium chloride. The 
primary antibodies were applied at room temperature for 2 hours, washed with 
blocking solution and then appropriate secondary antibody applied for 1 hour. After 
washing with TTBS (see Western blot), post fixing in 4% formaldehyde and 
counterstaining with DAPI, coverslips were observed with the Carl Zeiss AxioVert 
S100 TV microscope and a DeltaVision Restoration Microscopy System (Applied 
Precision Inc, Issaquah, WA) located at the Integrated microscopy core unit at Baylor 
College of Medicine. A Z-series of focal planes were digitally imaged and 
deconvolved with the DeltaVision constrained iterative algorithm to generate high 
resolution images. (Stenoien DL 2000 Subnuclear trafficking) (Agard DA 1984 
optical sectioning microscopy). 
9. Immunochemistry 
Immunocyto- and histo-chemistry  
Vectastain ABC systems were obtained from Vector Labs, Burlingame, CA. 
Fixation was performed with cold methanol 100% in -20 deg C for 5 minutes, 
followed by washing with 0.2% Triton X-100 in PBS for 10 minutes at room 
temperature. Quenching with peroxidase solution was performed for 10 minutes.  
Composition of peroxidase solution: 
30% H2O2   375 µL 
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100% Goat serum  110 µL 
PBS   32000 µL 
The slide was then washed in PBS for 10 minutes.  
In immunocytochemistry, as in immunofluorescent staining, a technique for 
conserving antibodies was performed by air drying slide and encircling area of 
interest with a wax pen. Subsequently, antibodies were only required to be instilled 
within the waxed area. 
Blocking was performed with 2 drops of avidin per section for 10 minutes. After 
aspirate, blocking with 2 drops of biotin 10 min. After rinsing with PBS once, 
blocking for non-specific binding was performed by addition of 20% goat serum in 
PBS for at least 40 minutes. All the secondary antibodies used in this study are goat 
antibodies.  
The primary antibody was then added and the section incubated overnight at 4 
degrees C or 1 hour at room temperature. 
Composition of primary antibody solution: 
100% Goat serum 20 µL 
Antibody  8 µL 
PBS   372 µL 
After washing 5 min three times, the secondary antibody solution (from Vectastain 
kit) was added for 30 minutes with gentle agitation. 
Composition of secondary antibody solution: 
Biotinylated goat anti-rabbit 10 µL 
PBS    1890 µL  
Goat serum    100 µL  
130 
After further washing of the slides or cells for 5 minutes three times, 100 µL of 
Vectastain Elite ABC was added with further incubation of 30 min and gentle 
agitation. 
Vectastain Elite ABC reagent: 
1 drop of reagent A 
2.5 mL PBS 
1 drop of reagent B 
Mix and settle for 30 min 
DAB solution was prepared freshly each use. 
Composition of DAB solution: 
5 mL distilled water 
3 drops Reagent 1 
2 drops Reagent 2 
2 drops Reagent 3 
2 drops H2O2 
After further washing as above, DAB solution was applied for 1-2 minutes. 
The section was rinsed gently and washed with water a few times to terminate the 
reaction.  
Counter staining was performed with Mayer’s Hematoxylin (diluted 3X in water) for 
a duration of 2 minutes. The sections were rinsed again 4 times before mounting the 
slide in gel. 
Immunofluorescent staining 
FisherBrand® superfrost®/Plus precleaned microscope slides (#12-550-15) was 
obtained from Fisher Scientific, Pittsburgh, PA. 
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Immunofluorescent staining was performed as described previously.(Chen et al 2004)  
Briefly, frozen human corneas were thawed and fixed with methanol, 4% 
formaldehyde or acetone at 4 oC for 5 minutes. After blocking with 5% normal goat 
serum in phosphate-buffered saline (PBS) for 30 minutes, a primary antibody (see 
Table 1) was applied at the specified dilution in 5% goat serum overnight at 4 oC. 
These and subsequent steps were performed at room temperature. After washing with 
PBS, the appropriate AlexaFluor 488 or 594 secondary antibody (1:300 dilution or 6.7 
µg/ml) was applied in 5% goat serum for 30 minutes in a dark incubation chamber. 
Counter-staining of cell nuclei was performed using 1 µg/mL propidium iodide in 
PBS for 2 minutes. Appropriate negative controls were incubated as above in the 
absence of primary antibody but with the various different secondary antibodies. 
If staining was performed on SecureslipTM coverslips, this would be carefully 
transferred to a glass slide (Fisher) before direct fluorescent microscopy or laser 
confocal scanning microscopy. 
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10. Western blot 
Western blotting was performed as previously described.(Luo et al 2004) Briefly, 
protein concentration was determined using the BCA method according to the 
manufacturer’s instructions.   
Ready Gels (#161-1158) containing 4-15% Tris-HCl and Precision Plus ProteinTM 
standards (#161-0363) was from Bio-Rad laboratories, Inc, Hercules, CA.  
Immobilon-P polyvinylidendifluoride (PVDF) membrane was from Millipore, 
Billerica, MA, USA.  The electrophoretic transfer buffer was a Tris/glycine buffer 
from Bio-Rad, Hercules, CA, USA. In addition to the main Tris reagent, the gel 
electrophoresis buffer also contains SDS whereas the transfer buffer contains 20% 
methanol.  
TTBS wash buffer composed of 0.1% Tween 20 (Bio-Rad, Hercules, CA, USA), 
50mM TRIS and 0.15 M sodium chloride at pH 7.5. Luminol Reagent was from Santa 
Cruz Biotechnology, Santa Cruz, CA, USA. 
Gel electrophoresis  
The same mass of protein (40 µg) was loaded per gel lane for electrophoresis. All 
protein solutions were mixed with a concentrated sample buffer containing beta-
mercaptoethanol (2 µL in 140 µL of 6X buffer) and boiled for 5 minutes before 
loading. To aid later identification of any protein bands detected by immunoblotting, 
protein standards with known molecular masses were loaded in one lane (Precision). 




Electrophorectic transfer to PVDF was performed with 20 V overnight or 120 V over 
90 minutes. Using this method, separated proteins were effectively transferred to a 
PVDF membrane. Blots were washed in TTBS, and all subsequent steps performed at 
room temperature. Blocking for non-specific proteins was performed for one hour in 
5% skimmed milk. 
Blotting and Visualisation 
Western blots were performed using the primary and secondary antibodies specified 
in the appropriate section. All dilutions were made in 5% skimmed milk in TTBS. 
Primary antibody incubation was for 1 hour. After further washing, the appropriate 
secondary HRP conjugated antibody was applied for a further hour in a rocker, at a 
dilution of 1:5000. Chemi-luminiscence was detected using Luminol (Santa Cruz, 
CA) and the Kodak imaging system 2000R (Eastman Kodak, New Haven, CT, USA). 
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11. Bead based sandwich immunofluorescent assay 
Beadlyte® cell signaling solutions, the human TNF-α BeadmatesTM and Beadlyte® 
human multi-cytokine BeadmasterTM kit were from Upstate, Lake Placid, NY. This is 
a high throughput bead-based immunofluorescent assay. 
The cytokine assay was used to determine the concentration of TNF-α in the culture 
media, whereas the cell signaling assay was used to determine the relative levels of 
total or phosphorylated p38, JNK and ERK in cell lysates.  
The assay was performed as in the manufacturer’s instructions. Briefly, cell culture 
media were aspirated from the wells after different intervals in experiments. The 
media were centrifuged and 25 µL of the supernatant used in each well of a 96 well 
plate for the cytokine assay. To prepare samples for cell signaling assays, Lysis buffer 
A or B (Upstate), with freshly added protease inhibitor (see section on cell lysis), was 
used to lyse cells. The most suitable buffer which gives the best activity for the 
selected BeadmatesTM would be used. 5 ml of buffer was used per 15 cm dish at room 
temperature. 
Diluted antibody capture beads as well as the biotin labeled reporters, followed by the 
Streptavidin-Phycoerythrin (all from Beadlyte kit) were added as in the 
manufacturer’s instructions. As a general rule, over night incubation of proteins with 
the capture beads was performed, in a shaker at 4 degrees C. 
A Luminex® 100 TM machine, with Luminex® software was used to determine the 
fluorescence of each sample. The machine was set up to read the fluorescence of 100 
beads per well. In the case of human cytokine assay, a standard curve was constructed 




500 µg of the cell lysate (in 50 mM Tris HCl, pH 8.0, 150 mM NaCl and 1% NP-40)  
was pre-cleared by incubation with 50 µl of Trueblot anti-mouse or anti-rabbit IgG-
coated beads (eBiosciences, San Diego, CA). Five micrograms of the primary 
antibody (p65, rabbit polyclonal, SC-109 from Santa Cruz; or IкBa, SC-371 from 
Santa Cruz or TGM-2, CUB74 from Neomarkers) was then added to the pre-cleared 
cell lysate and incubated for 1 h at 4 °C. Immune complexes was recovered using the 
Trueblot anti-mouse or anti-rabbit IgG-coated beads (incubated overnight at 4 °C).  
At the end of incubation, pellets will be washed four times in ice-cold Tris-buffered 
saline (50 mM, pH 8.0) and resuspended in 50 µl of 1X loading buffer. 
Immunoprecipitates was analyzed by SDS-PAGE, followed by immunobloting or 
other procedures such as nano LC.  
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13. Reporter assays 
The secretary alkaline phosphatase assay SEAP (Clontech) was used to detect NF-κB 
dependent transcriptional activity. The pSEAP expression vector is a plasmid that 
produces SEAP, in the presence of transcription complex binding to the promoter, 
which can be detected by sampling the culture medium of cells. Subsequently the 
amount of SEAP can be quantified by a chemi-luminescent method in a 96 well 
format with the aid of a standard curve using known concentrations of alkaline 
phosphatase standards. 
For a negative control, a basic pSEAP vector is used, and for positive control, a 
control pSEAP vector with constitutively active promoter instead of the NF-κB 
dependent promoter was used. 
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14. Polymerase chain reaction 
Reverse transcription 
PCR Buffer II (E12848) was obtained from Applied Biosystems, Foster City, CA, 
USA. Ready-To-Go You-Prime First-Strand Beads was obtained from Amersham 
Pharmacia Biotech, Inc., Piscataway, NJ, USA. PCR Master Mix AmpErase UNG, 
Taqman MGB probes for SPRR1A, SPRR1B, SPRR2A and SPRR2B with assay ID 
Hs00954595_s1, Hs00824893_m1, Hs01655189_sH, Hs00863465_m1 respectively 
were from Applied Biosystems, Foster City, CA, USA. 
Semi-quantitative PCR 
Reverse transcription-polymerase chain reaction (PCR) was performed as described 
previously.(de Paiva et al 2005) Briefly, total cellular RNA was extracted. Reverse 
transcription was performed using Magnesium chloride (5mM), deoxynucleotides 
(1mM each), RNAase inhibitor (1u/µL), reverse transcriptase (2.5 unit/µL) and 
random hexamers (2.5 uM) in PCR buffer II. PCR was performed using a custom 
designed nucleotide primer against a unique part of the respective human mRNA or 
cDNA (see Table 2). cDNA amplification was performed with an individually 
optimized number of cycles and temperatures for each primer. Controls included the 
housekeeping gene GADPH, as well as non-irradiated samples incubated for the same 
duration as the irradiated samples. The relative amount of mRNA detected was 
indicated by the relative intensity of the ethidium bromide stained bands (which was 
an indicator of the amount of amplicon produced at the end of the PCR) on 
electrophoresis of PCR products in 2% agarose gel. 
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Real time RT-PCR 
For the relative quantification of mRNA levels, real-time RT-PCR was employed.  
Two different methodologies were adopted. 
Method 1 
The first-strand cDNA was synthesized from 1 µg of total RNA with random hexamer 
using M-MuLV reverse transcriptase (Ready-To-Go You-Prime First-Strand Beads) 
as previously described.(Corrales et al 2003, Luo et al 2004) Real-time PCR was 
performed using specific Taqman MGB probes, a Taqman Universal PCR Master 
Mix AmpErase UNG, and a commercial system (Smart Cycler System; Cepheid, 
Sunnyvale, CA, USA) according to the manufacturer’s recommendations. Assays 
were performed in duplicate, in 2 different experiments. A non-template control was 
included to detect DNA contamination. The GAPDH gene was used as an endogenous 
reference for each reaction to correct differences in the amount of total RNA added. 
The results were analyzed by the comparative CT method; (Applied Biosystems User 
Bulletin, No.2, P/N 4303859)(Luo et al 2004) where target fold= 2 -∆∆Ct.  The cycle 
threshold (Ct) was determined as the cycle at which the primary (fluorescent) signal 
crosses a user-defined threshold. The results were normalized by the Ct value of 
GAPDH and the relative mRNA level in the non-irradiated or the youngest cell group 
(calibrator).  
Method 2 
The first-strand cDNA was synthesized from 1 µg of total RNA using the following 
reaction volumes within one reaction: 
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OligodT  0.5 µL 
RNA   appropriate volume for 1 µg 
Water   (4.5- volume of RNA) 
For a sub-total of 5 µL, which was incubated in a PCR machine at 65 deg C for 15 
min. Subsequently this was transferred to ice for 15 min while preparing the 
following master mix: 
Water   1.5 µL 
5X buffer  2 µL 
dNTP   0.5 µL 
RNAse inhibitor 0.5 µL 
Superscript II Reverse transcriptase 0.5 µL (Invitrogen Life Tech, Carlsbad, CA) 
For a sub-total of 5 µL per reaction. 
This 5 µL will be added to the RNA/OligodT solution to give a final volume of 10 µL. 
This final solution was incubated at 42 °C for 60 min, followed by 70 °C for 10 min 
then 4 °C. 
In general the cDNA was diluted 1:50 times before being used as templates for 
relative quantitative real time polymerase chain reaction.  
 
Gene specific expression quantification assays were designed using the web-based 
ProbeFinder software (www.universalprobelibrary.com). Intron-spanning assays were 
selected to remove false signals from the amplification of any genomic DNA if 
present as contamination. When primers have been designed, they were custom 
synthesized using a commercial service (First Base Pte Ltd). In conjunction with one 
of the appropriate pre-synthesized hydrolysis probes (specified by the ProbeFinder 
software) from the human Universal Probe Library set (#04 683 633 001, Roche 
Applied Science, Mannheim, Germany), real time PCR can be performed.  This 
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library contains 90 distinct probes labeled from #1 to #90, covering 98% of the human 
gene transcripts. The 5’ end of the probe was labeled with fluorescein (FAM) and the 
3’ labeled with a dark quencher dye. These dual labeled probes (8-9 nucleotides 
length) have inclusion of duplex stabilising DNA analogues or Locked Nucleic Acid 
(LNA) to ensure specificity, melting temperature and compatibility. 
Each reaction within a single well of 384 well plate with a total volume of 10 µL was 
used, with technical duplicates. The single reaction mix consisted of 0.1 µL of 
forward primer, and 0.1 µL of reverse primer (at 20 µM in each case), 0.1 µL of the 
probe from the library, and 5 µL of a 2X Master Mix (#04 707 494 001, Roche 
Applied Science), 2.5 µL of cDNA and the appropriate volume of PCR-grade water to 
make up the final volume. 
Pipetting was carefully performed to avoid formation of air bubbles within the wells. 
Centrifuging of plates was performed at 2000 g for 2 minutes at 4 °C. 
The actual real time PCR was performed using the Lightcycler 480 System (Roche 
Diagnostics, Basel, Switzerland) together with the Lightcycler 480 software release 
1.2.0.0625 (Idaho Technology, Inc). As a ‘default’ setting, the following cycling 
conditions were adopted: 
Preincubation: 95°C at 10 minutes (rate rate 4.8 °C/sec) 
Amplication was performed by cycling the following conditions (up to 45 cycles if 
necessary): Denaturation at 95°C for 10 s (ramp rate of 4.8 °C/sec), annealing at 60°C 
for 10 s (ramp rate of 2.5 °C/sec) and extension at 72°C for 10 s (ramp rate of 4.8 
°C/sec) in each cycle. After the amplication, incubation was performed at 40°C (ramp 
rate 2.5 °C/sec). 
Detection of FAM signals was performed using a filter that detects light of 483-
533nm wavelengths. A no-template control was included to detect DNA 
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contamination. The GAPDH gene was used as an endogenous reference for each 
reaction to correct differences in the amount of total RNA added. Calibrator 
normalized relative quantification without standard curves was employed (ΔΔCt 
method).  
In order to detect TGM2 transcripts, the following primers were used, in conjunction 
with probe #86: 
Forward (5’ to 3’): agg gtg aca aga gcg aga tg 
Reverse (5’ to 3’): tgg tca ttcc acg act cca c 
When the TGM2 assay was used for the first time, standard curves were obtained for 
different dilutions of the cDNA after reverse transcription (1:10, 1:50, 1:100) of 1 µg 
of total RNA from HCE-T. The mean (n=3) crossing point corresponding to these 
dilutions were 25.59 (SD 0.096), 27.74 (SD 0.103) and 28.53 (SD 0.095) respectively. 
In order to detect GADPH, the following primers were used, in conjunction with 
probe #60: 
Forward (5’ to 3’): agc cac atc gct gag aca 
Reverse (5’ to 3’): gcc caa tac gac caa atc c 
As a modification of this technique, a GADPH Cal Red probe was synthesized (First 
Base Pte Ltd). The sequence of the probe was 5’/5Cal610/TGG GGA AGG TGA 
AGG TCG G/3BHQ_2/3’. The Cal Red 610 labeled amplicons were detected using 
the 558-610 nm channel. Since there was no overlap between this and the channel for 
detection of FAM signals, multiplexed assays could be performed using a FAM probe 
to detect the transcript of interest and the Cal Red probe to detect the housekeeping 
gene transcript GADPH, serving as a loading control. Initial evaluation showed that 
when the TGM2 assay was duplexed with the Cal Red GADPH assay, the FAM 
signal was reduced to 30% of its original value (which was obtained in a monoplex 
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TGM2 assay), and that the Cal Red signal reduced to 45% of its value in the 
monoplex assay. In order to optimise the multiplexing reaction, various ratios of 
primers for detection of TGM2 to the primers for detection of GADPH, as well as 
ratios of the TGM2 probe to the GADPH probe, were evaluated. Using this 
optimisation protocol, the optimal reaction mix for a TGM-2 GADPH multiplex assay 
was found to be as follows: 
Probe master mix (2X) : 5 µL 
GADPH primers (each 20 µM primer 0.05 µL): 0.1 µL  
Cal Red 610 probe (detects GADPH related amplicons) stocked as 10 µM: 0.05 µL 
TGM2 primers (each 20 µM primer 0.15 µL): 0.3 µL  
FAM probe #86 (detects TGM2 related amplicons) supplied as 10 µM: 0.15 µL 
cDNA template (1:10 dilution) : 4.4 µL 
Total volume: 10.0 µL 
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15. Functional assays 
MTT cell proliferation/ viability assay 
MTT assay was performed per the manufacturer’s instructions. Briefly, a standard 
curve of known cell concentrations against absorbance showed that a portion of the 
curve was approximately linear. This was used to derive the optimal seeding 
concentration of 2X105 cells/ml. For each experimental condition, cells were seeded 
at this density in a volume of 100µL per well on a 96 well plate in triplicate. The 
tetrazolium compound MTT (3-[4,5-dimethylthiazol-2-yl]2,5-diphenyltetrazolium 
bromide) was added 24 hours after UVB. Detergent reagent was added 2 hours after 
addition of MTT and incubated at 37 degrees Celsius for a further 24 hours. The 
absorbance was then read at 570 nm using a reference wavelength of 650 nm. 
MTS assay 
For this purpose, the Cell titre 96 Aqueous One Solution Cell Proliferation Assay 
(Promega, Madison, WI) was used. This commercially available assay is a 
colorimetric method for determining the number of viable cells. The CellTiter 96® 
AQueous One Solution Reagent contains a tetrazolium compound [3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-
tetrazolium, inner salt; MTS(a)] and an electron coupling reagent (phenazine 
ethosulfate; PES). PES has enhanced chemical stability, which allows it to be 
combined with MTS to form a stable solution. The MTS tetrazolium compound 
(Owen.s reagent) is bioreduced by cells into a colored formazan product that is 
soluble in tissue culture medium. This conversion is presumably accomplished by 
NADPH or NADH produced by dehydrogenase enzymes in metabolically active cells 
(2). Assays are performed by adding a small amount of the CellTiter 96® AQueous 
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One Solution Reagent (20 µL per well of a 96 well plate) directly to culture wells, 
incubating for 2 hours and then recording the absorbance at 490nm with a 96-well 
plate reader. The quantity of formazan product as measured by the absorbance at 
490nm is directly proportional to the number of living cells in culture. 
Fluorescein cadaverine uptake (in cells and in lysates) 
Fluorescein cadaverine was added to culture media at a final concentration of 0.5 
mM, and incubated in the usual cell culture conditions for 24 hours in the dark. 
Visualisation of cultured cells was performed using an inverted microscope after 
removing the media and thoroughly washing with PBS. 
For quantification of fluorescence, cells were washed 5 times with PBS 2 minutes 
each wash. 300 µL of M-PER lysis buffer was added per well of a 6 well plate. Scrape 
cells and collect in an Eppendorf tube. Spin at 13000 g for 1 minute. Load 100 µL of 
supernatant in each well of a 96 well plate (at least in duplicates). Use blank controls 
with cells un-incubated with fluorescein cadaverine. The relative fluorescence levels 
of experimental samples and controls were read using a CytoFluorTM II fluorescence 
Multi-well plate reader (Perseptive Biosystems, Framingham, MA).  
Trans-epithelial electrical resistance and trans-epithelial 
passage of dextran 
The in-vitro barrier property of the CEC was assessed by measuring the trans-
epithelial electrical resistance (TER) before and 24 hours after UVB. Growth medium 
was used at 500 µL within each insert and 1500 µL in the bottom of each well outside 
the insert. TER was measured with the EVOM voltmeter using the 4mmX1mm 
‘Chopstick’ silver electrodes (World Precision Instruments, Sarasota, FL). TER was 
measured 3 times for cells in each insert (over 3 different sectors of the insert), with 
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the microelectrodes placed vertically, by the same observer. Inserts with culture 
media and no cells were designated as ‘blanks’. The TER measured in blank inserts 
was subtracted from the TER value for other inserts. TER was measured just before 
the commencement of UVB stimulation. The final measurement was performed by 
the same observer 24 hours after UVB stimulation. The 24 hour measurement was 
performed immediately after replacing all CEC wells with fresh media (including 
controls and blanks). This was shown to increase the repeatability of TER. 
 
Preliminary studies included the measurement of TER after different UVB energies, 
as well as the use of different concentrations of MDC without UVB stimulation. In 
order to validate the TER measurement of barrier function, the passage of 10 kDa 
dextran-Alexa 488 conjugate (DEC) (Molecular Probes, Eugene, OR) was used to 
assess permeability in one experiment after TER measurement was completed. DEC 
was added to the center of inserts at a concentration of 200 µg/mL and 100 µL of 
media outside the inserts was harvested after one hour of incubation. Media within the 
inserts were also extracted. The concentration of the DEC in the media samples was 
determined by reading the absorbance of the samples using a CytoFluor II 
fluorescence multi-well plate reader (Perseptive Biosystems, Framingham,  MA), 
calibrating against a standard curve of fresh samples of known DEC concentrations. 
Correlation analysis was used to compare the TER values at 24 hours with the 
calculated concentration of DEC obtained. 
TUNEL assay 
Terminal deoxynucleotidyl transferase-mediated dUTP-digoxigenin nick end labeling 
(TUNEL) assay was performed using the ApopTag Fluorescein kit as previously 
described.(Yeh et al 2003) Briefly, cells were seeded into an 8 well chamber slide for 
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this experiment. UVB irradiation was performed as above, and TUNEL protocol 
performed 8 and 16 hours after UVB. Sampling of cells was performed by counting 
propidium iodide stained nuclei for each condition. At least 400 cells were counted 
for each experimental group. Positive cells were identified by fluorescent staining 
associated with the sampled cells at the same exposure, brightness, contrast and 
magnification between experimental groups. This is facilitated by overlapping 
fluorescent images with propidium iodide staining images in different layers of a 
composite image in Adobe Photoshop version 6.0 (Adobe Systems Inc, San Jose, 
CA).  
Caspase activation assay 
This was performed as for immunofluorescent staining of fixed cells. After 
completion of staining, the imaging and counting of caspase positive cells was 
performed as for the TUNEL positive cells. 
Caspase activity assay 
This was performed using the Caspase-Glo 3/7, 8 and 9 (Promega, Madison, WI) for 
detection of caspase subtype activities respectively. These commercial luminescent 
assays are based on the cleavage of specific caspase substrates. The luminogenic 
substrates were provided in a buffer system optimized for cell lysis, caspase and 
luciferase activity. The signal generated was proportional to the amount of caspase 
activity present, and was detected by the 96 well Genios Pro-reader. 
Cytotoxicity assay 
This was performed using the MultiTox-Fluor Multiplex cytotoxicity assay (Promega, 
Madison, WI). This was a commercially available single reagent addition fluorescent 
assay that simultaneously measures the relative number of live and dead cells in cell 
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populations. The assay provided ratiometric, inversely correlated measures of cell 
viability and cytotoxicity. The ratio of viable cells to dead cells is independent of cell 
number and therefore can be used to normalise data. 
The assay simultaneously measures two protease activities, one a marker of cell 
viability and the other a marker of cytotoxicity. The live-cell protease activity is 
restricted to intact viable cells and is measured using a fluorogenic, cell-permeant, 
peptide substrate (glycyl-phenylalanyl-amino-fluorocoumarin; GF-AFC). The 
substrate enters intact cells where it is cleaved by the live-cell protease activity to 
generate a fluorescent signal proportional to the number of living cells. This protease 
becomes inactive upon loss of cell membrane integrity and leakage of cell contents 
into surrounding culture medium. A second, fluorogenic cell-impermeant peptide 
substrate (bis-alanyl-alanyl-phenylalanyl-rhodamine 110; bis-AAF-R110) is used to 
measure dead cell protease activity, which is released from cells that have lost 
membrane integrity. As this substrate is not cell permeable, no signal from it is 
generated by intact viable cells. The live- and dead- cell proteases produce different 
products, AFC and R110, which have different excitation and emission spectra, 
allowing them to be detected simultaneously. 
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16. Gel shift assays 
The electrophorectic mobility gel shift procedures had been performed by Amit Hazra 
at the Institute of Cell and Molecular Biology, Singapore. 
Construction of the probe 
A 27 mer containing the internal κB consensus site (decameric) was end-labeled with 
T4 polynucleotide kinase and dATP. This was the composition of the labelling mix: 
20-50 ng ds oligonucleotides 
2 µL 10X T4 polynucleotide kinase buffer 
1 µL δ32P ATP 
1 µL T4 polynucleotide kinase enzyme 
dH2O to 20 µL final volume 
The mixture was incubated at 37°C for 1-2 hours. 50 µL of dH2O was then added and 
applied to G50 sepharose spin column and centrifuged at 3000 rpm for 6 min. The 
probe was then diluted so that 1 µL measured about 200 cps (104 – 105 cpm) when 
held close to the Giger counter. The probe was stored at –20°C and used within 2 
weeks. 
Preparation of gel  
A 4% polyacrylamide/0.25X TBE gel was used to separate the samples. The was the 
ingredient list: 
Acrylamide Bis-acryl (30:2)  6.7 µL 
10X TBE   1.25 µL 
Water    42 mL 
10%APS   500 µL 
TEMED   50 µL 
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The gel was cast within glass plates separated by spacers of 1.5 mm thickness. A 15 
well gel was cast (with each well able to contain 20 µL of sample). 
Preparation of nuclear extracts 
Cells were treated with a hypotonic buffer to lyse the plasma membrane. Nuclear 
proteins were extracted by osmotic flow using high salt buffer. 
Composition of Buffer A: 
10 mM Hepes (pH 7.9) 
1. 5mM MgCl2 
10 mM KCl 
0.5 mM DTT 
0.2 mM PMSF 
2 µg/mL Aprotinin 
Composition of Buffer C 
20 mM Hepes 
25% Glycerol 
0.45 M NaCl 
1.5 M MgCl2 
0.2 mM EDTA 
0.5 mM PMSF 
0.5 mM DTT 
When the cells were ready for assessment of NF-κB activity, the cells were 
trypsinised, and pelleted, and kept at –80°C. To commence the assay, the cells were 
thawed on ice and vortexed to break up. Buffer A was added (400 µL) for every 
million cells, and the tube was flicked to suspend, pipetted up and down 8 times with 
a pipette, and incubated on ice for 15 minutes. This was then vortexed and centrifuged 
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at 6000 rpm for 5 min at 4°C. The supernatant was removed: this was the cytoplasmic 
extract. The nuclear pellet was resuspended with buffer C (using the same volume of 
the buffer as the volume of the pellet). This was incubated on ice for 20 min, 
occasionally vortexing every min, and finally centrifuged at 12000 rpm for 2 min. The 
supernatant was the nuclear extract which was stored at -70°C. Protein concentration 
was measured. The ideal concentration was at least 2 µg/µL.  
DNA binding reaction 
The nuclear extracts were mixed with the end labelled probe and run on the gel 
mentioned above. 
Preparation of the 5X DNA binding buffer was performed by adding: 
214 g of NaCL to get 375mM NaCl 
750 µL of TRIS to get 75 mM TRIS (pH 7.5) 
150 µL EDTA to get 7.5 mM EDTA (pH 8) 
150 µL DDT to get 7.5 mM DTT 
25 µL glycerol to get 25% glycerol 
100 µL BSA stock to get 100 µL/mL BSA 
The mixture was then added as follows: 
5 µg nuclear extract 
2 µL 5X binding buffer 
0.5 µL poly dIdC (Pharmacia) 
dH20 was added to give final volume of 9 µL. 
The mixture was incubated on ice for 20 min and 1 µL of labelled oligo-nucleotide 
probe was added and incubated at room temperature for 30 min. The sample was 
loaded into the gel well and electrophoresis was performed at 150 V over 2 hours or 
until the bromophenol blue reaches within 2 inches from the bottom of the gel. The 
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gel was dried on Whatman paper and exposed to X ray film overnight at room 
temperature within screen. 
Controls for gel shift 
Mutant oligonucleotide competition: 10-20 ng (0.5 µL) of stock (cold) oligo 
nucleotide was added to the prebinding raction (before addition of probe) and 
electrophoresis performed as usual. 
Antibody supershift: 0.5-1.0 µL of antibody was added to the pre-binding reaction 
to identify proteins such as NF-κB family members in a particular gel shift band. 
DOC/NP40 treatment of cytoplasmic extract: To test the integrity of the gel shift 
procedure, 5 µg of cytoplasmic extract would be used instead of nuclear extract. 
The pre-binding reaction was treated with 0.8% DOC for 10 min on ice, then 
1.2% NP40 was added for another 10 min. The probe was then added which binds 
to any IκBα liberated NF-κB. 
Oct-1 probe. This is a ubiquitous nuclear DNA binding protein that is often used 
to determine integrity of the nuclear extract. The Oct-1 consensus would replace 
the NF-κB probe (Santa Cruz) and the gel shift performed in the same way. 
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17. GeneChip Microarray Experiments 
 
Preparation of Dilutions of Poly-A Controls 
For this purpose, the GeneChip Poly-A RNA Control Kit was used. The dilution 
buffer provided was used to do all the dilutions, as the Poly-A RNA controls are 
provided as a concentrated stock. The required minimum of 1 µg of total RNA was 
used in a maximum volume of 3.2 µL. The exact volume would depend on the RNA 
concentration in the samples extracted. RNA extraction would be performed as 
described in the earlier appendix A7. 
2 µL of Poly-A RNA Control Stock was added to 38 µL of Dilution Buffer to make 
First Dilution (1:20).  This was mixed thoroughly and spun down. 2 µL of the First 
Dilution was added to 98 µL of Dilution Buffer to make the Second Dilution (1:50). 
This was again mixed and spun down. 2 µL of the Second Dilution was added to 98 
µL of Dilution Buffer to make the Third Dilution (1:50). The mixing and centrifuging 
was then repeated. Following this, 2 µL of the Third Dilution was added to 1 µg of 
RNA to make up the Total RNA/Poly-A RNA Controls Mix. 
Preparation of Hybridization Buffer with Betaine 
For this purpose, the RiboMinus Human/Mouse Transcriptome Isolation Kit 
(Invitrogen) was used. The buffer was prepared as follows: 
Component Volume for 1 
reaction 
Betaine, 5M 54 uL 
Invitrogen Hyb buffer 126 uL 
Total volume 180 uL 
 
In a 0.2 ml strip tube, the following components were mixed: 
Component For samples of 1 µg/µL, 
the following volumes 
For samples 0.31 µg/µL 
to 1 µg/µL, the following 
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were used (µL) volumes were used (µL) 
Total RNA/Poly-A 
controls mix 
3  Up to 5.2 
RiboMinus Probe, 100 
pmol/µL 
0.8  0.8  
Hybridization Buffer with 
Betaine 
20  30  
Total Volume 23.8  36  
 
The mixture was flicked, spun down, and incubated at 70 °C for 5 min, then placed on 
ice while preparing magnetic beads. 
The block was heated to 37 °C. 50 µL of beads suspension was pipetted into a 1.5 ml 
tube, and placed in the magnetic stand for 1 min. The supernatant was aspirated out 
without drying out the beads. 50 µL Rnase-free water was added to the beads and the 
beads resuspended. The tube was then placed on the stand for 1min. This procedure 
was then repeated. 50 µL of Hybridization Buffer with Betaine was added to the 
beads and the beads resuspended. The tube was then placed on a magnetic stand for 1 
min, followed by removal of supernatant. Finally, the beads were resuspended in 30 
µL of Hybridization Buffer with Betaine, and kept at 37°C for 2 min. 
rRNA Reduction 
For this purpose, two heating blocks were prepared: 37°C and 50°C. 
The ice-cooled hybridized sample was transferred to the beads, mixed well and spun. 
The tube was then incubated at 37°C for 10 min. After 5 min, the tube was gently 
flicked, briefly spun and and incubated in the magnetic stand for 2 min to obtain the 
rRNA-probe pellet. The supernantant at this point contained the rRNA-reduced total 
RNA/poly-A RNA controls mixture. The supernatant was transferred to a 1.5 ml tube 
and left on ice.  
The beads were resuspended in 50 µL of Hybridizatoin Buffer with Betaine and 
incubated at 50°C for 5 min. The tube was placed on a magnetic stand for 2 min. The  
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supernatant was combined with the supernatant that was collected in the previous 
step. (~100 µL) 
Concentration 
For this purpose the GeneChip IVT cRNA Cleanup Kit was used. Firstly, 20 ml of 
ethanol would have been added to the cRNA Wash Buffer, if the kit has been used 
previously. 350 µL of cRNA Binding Buffer was added to each rRNA-reduced 
sample and vortexed for 3 s. 250 µL of absolute ethanol was added to each reaction 
and flicked to mix. The sample was applied to the IVT cRNA Cleanup Spin Column 
and spun at 8,000 g for 15 s, and the flow through discarded. 
The column was transferred to new 2 ml tubes and 500 µL of cRNA Wash Buffer 
added and then spun at 8,000 g for 15 s. After this, the flow-through was discarded. 
The washing was repeated with 500 uL 80% ethanol. (Spun for 15 s at 8,000 g and 
flow-through discarded). The cap was opened and spun at maximum speed for 5 min. 
The spin column was then transferred to a new 1.5 ml tube and 11 µL of Rnase-free 
water added. Spin at max speed for 1 min. 
Preparation of rRNA-Reduced Total RNA/ T7- (N)6 Primers/Poly-A 
RNA Controls 
For this purpose the GeneChip Whole Transcript (WT) cDNA Synthesis Kit was 
used. The T7-(N)6 primers was diluted 1:4 with water from a stock of 2.5 µg/µL to 
make up a 500 ng/µL working solution. The diluted T7-(N)6 Primers were mixed 
with the concentrated rRNA-Reduced Sample. 
Component Volume (µL) 
rRNA-Reduced Total RNA/Poly-A 
RNA Control Mix 
4  
Diluted T7-(N)6 primers, 500 ng/uL 1  
Total volume 5  
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The tube was flicked, spun and incubated at 70°C  for 5 min and then at  
   16°C for 2 min. This was spun and placed on ice. 
First cycle, 1st str cDNA synthesis 
For this purpose, the GeneChip WT cDNA Synthesis Kit was used. In separate tubes, 
the reagents for the First strand MasterMix was prepared. 
Component Volume for 1 reaction (µL) 
5X 1st str buffer 2  
DTT 0.1M 1  
Rnase inhibitor 0.5 
DNTP 10mM 0.5 
Superscript II 1  
Total 5  
 
5 µl (4.5 µL) of Mastermix was added to 5 µL of primed RNA, flicked to mix, spun 
down and incubated at the following settings: 
o 25 deg for 10 min 
o 42 deg 1hr-RevTrans, 1st str 
o 70 deg 10min-denat Revtase 
o hold at 4 °C (for at least 2 min but not more than 10 min) 
First cycle, 2nd str cDNA synthesis 
For this purpose, the GeneChip WT cDNA Synthesis Kit was used. The mastermix 
prepared would be for at least 4 reactions for accuracy. The MgCl2 was freshly 
prepared- : 2 µL of 1M MgCl2 was added to 112 µL of water to make up 17.5 mM of 
MgCl2. 
Component Volume for 1 Reaction (µL) 
Rnase free water 4.8  
Fresh MgCl2 17.5mM 4  
DNTP 10mM 0.4  
E coli DNA pol I 0.6  
Rnase H 0.2  
total 10  
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The mixture was flicked and spun down. 10 µl (9.5 µl per reaction) of the 2nd 
strMasterMix was added to 10 µl of 1st str Reaction (total 20 µL). The incubation was 
then at the following settings: 
16°C 2hrs without heated lid- 2nd str synthesis 
75°C 10 min with heated lid- to denature polymerase 
4°C hold (at least 2min but not more than 10 min) 
First Cycle cRNA Synthesis and Cleanup 
For this purpose the GeneChip WT cDNA Amplification Kit and the Genechip 
Sample Cleanup Module was used. The in-vitro transcription (IVT) reagents from kit 
were thawed at room temperature (storage was at –20°C).  
The IVT MasterMix was prepared as follows: 
Component  Volume of one 
reaction (µL) 
10X IVT Buffer 5  
IVT NTP Mix 20  
IVT Enzyme mix 5 
Total for one reaction 30 
 
At room temperature, 30 µl (29.5 µl) of IVT Mastermix was added to each cDNA 
sample (20 ul) to make a total of 50 µl. This was flicked, spun down, incubated at 
37°C for 16 hours, and held at 4 °C. At this stage, the mixture was flicked, spun down 
and continued or stored at –80°C.  
The following GeneChip Sample Cleanup Module components were prepared: 
 96-100% ethanol 
 80% ethanol 
 20 mL of ethanol (100%) was added to cRNA wash buffer 




50 µl of Rnase-free water was added to the IVT reaction, and vortexed for 3 sec (total 
volume = 100 µl). 
350 µl of cRNA Binding Buffer was added and vortexed for 3 sec (this was a salt 
buffer). Following this, 250 µl of absolute ethanol was added and mixed by pipetting 
without spinning down. 
Binding 
The sample (700 µl) was applied to the spin column and spun for 15sec at >8,000 g 
and repeated. 
Washing 
500 µl of cRNA Wash Buffer was added and spun at 15 sec for >8000 g and 
discarded. 500 µl of 80% ethanol was added to the column and spun at 30sec at >8000 
g and the flow-through discarded. 
Drying 
The column was placed into a new collection tube, the cap opened and spun dry for 5 
mins at the maximum setting of  25,000 g. 
Elution 
The sample was placed into 1.5ml tubes and eluted with 12 µl Rnase-free water, and 
stood for 1 min before centrifuging. This procedure was repeated, followed by 
spectrophotometry (Nanodrop technique) for cRNA concentration. Each tube was 
expected to have 20 to 60 µg of cRNA. 
2nd cycle First Strand cDNA synthesis 
For this purpose the GeneChip WT cDNA Synthesis Kit was used. 1.5 ul of random 
primers (3 µg/uL) was added to purified cRNA (10 µg). Rnase-free water was added 
to a final volume of 8 µL. The incubation was performed at the following setting: 
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70°C 5min-priming  
25 °C 5 min 
4 °C hold for at least 2 min- cooling sample 
In a new tube, the 2nd cycle 1st str Mmix was prepared as follows (making one 
reaction more): 
Component 
Volume of  1 
reaction (µL) 
5X 1st str buffer 4  
DTT 0.1M 2  
dNTP + dUTP 10mM 1.25  
SuperScript II 4.75  
Total for one reaction 12 
 
12 µl (11.5 µl) of Mastermix was added to each random primer primed cRNA. Total 
volume would be 20 µl. The mixture was flicked, spun and incubated at 
o 25 °C  10 min 
o 42 °C  90 min-RT, 1st str syn 
o 70 °C  10 min 
o hold 4°C (for at least 2 min)- cooling sample 
Hydrolysis of cRNA and Cleanup of Single-Stranded DNA 
24 mL of ethanol(100%) was added to the cDNA Wash Buffer. The GeneChip WT 
cDNA Synthesis Kit and the GeneChip Sample Cleanup Module were used. 
1 µL of Rnase H was added to each sample and incubated at: 
37 °C 45 min 
95 °C 5 min 
16 °C 2 min 
The cleanup was performed using cDNA Cleanup Spin Columns. 80 µL of RNase-
free water was added to each sample, followed by 370 µL of cDNA Binding Buffer 
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and vortexed for 3 sec. The sample was applied  to the cDNA Spin Column, spun atin 
at >8, 000 g for 1 min and the flow-through discarded. The sample in the cDNA 
Cleanup Spin Column was transferred to a new 2 mL Collection Tube and 750 uL of 
cDNA Wash Buffer added to the column. After spinning at >8, 000 g for 1 min the 
flow-through was discarded. The cap of the column was opened and the column spun 
at maximum speed for 5 min. The column was then placed in a new 1.5 mL collection 
tube. 15 µL of the cDNA Elution Buffer was pipetted, incubated for 1 min, and spun 
at maximum speed for 1 min. The elution step was repeated by pipetting another 15 
µL of the elution buffer and similarly spun. On determination of the DNA 
concentration, each tube should have > 5.5 µg of single-stranded DNA. 
Fragmentation of Single-Stranded DNA 
For this purpose the GeneChip WT Terminal Labeling Kit was used. The sample was 
fragmented using the following components: 
Component Volume/amount 
Single-Stranded DNA 5.5 µg 
10 x cDNA Fragmentation Buffer 4.8 µL 
UDG, 10U/µL 1.0 µL 
APE 1, 1,000U/µL 1.0 µL 
Rnase-free water Up to 48 µL 
Total volume 48 µL 
 
The Fragmentation Master Mix was added to the samples after cRNA Hydrolysis and 
Cleanup, and mixed and spun.  The reaction was incubated at: 
 -37 °C 60 min 
    -93 °C 2 min 
    -16 °C for 2 min 
The reaction was flicked and mixed. 45 µL of the sample was transferred to a new 
tube, the remaining sample would be used for size analysis using the Bioanalyzer. 
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Here the fragmented DNA could be stored at –20°C if the experiment was to be 
temporarily halted. 
Labeling of Fragmented Single-Stranded DNA 
For this purpose the GeneChip WT Terminal Labeling Kit was used. 
Component Volume (µL) 
Fragmented Single-Stranded DNA 45  
5 x TdT Buffer 12  
TdT  2  
DNA Labeling Reagent, 5 mM 1  
Total 60  
 
The reaction was flicked and mixed and incubated at: 
37 °C 60 min 
70 °C 10 min 
16 °C 2 min 
Hybridization 
Three heating blocks at 65 °C , 99 °C and 45 °C were prepared. The hybridisation 
cocktail was prepared in a 1.5 mL tube as follows. 
Component Volume for 





Fragmented and Labeled DNA Target ~ 60  ~5.5 µg 
Control Oligonucleotide B2 3.7  50 pM 
20X Eukaryotic Hybridization Controls 11   
Herring Sperm DNA (10 mg/mL) 2.2  0.1 mg/mL 
Acetylated BSA  (50 mg/mL) 2.2  0.5 mg/mL 
2 X Hybridization Buffer 110  1X 
DMSO 15.4   7% 
Rnase-free water Up to 220   
 
The 20x Eukaryotic Hybridizatoin controls were heated to 65 °C for 5 min before use. 
The Hybridization Cocktail was heated to 99 °C for 5 min, cooled to 45°C for 5 min, 
and spun at maximum speed for 1 min. The Exon Array was equilibrated to room 
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temperature before use. 200 µL of the specific sample was injected into the array. The 
array was placed in 45 °C hybridization oven, at 60 rpm, and incubated for 16 hours. 
Preparing the Staining Reagents 
 
SAPE solution mix 
Component Vol 1 of one reaction (µL) Final 
Concentration 
2 X Stain Buffer 300  1 X 
50 mg/mL BSA 24  2 mg/mL 
1 mg/mL SAPE 6  10 µg/mL 
Mol. Bio water 270   
Total  600   
 
The solution was mixed well, and 600 µL was used for the 1st and 3rd staining. 
 
Antibody Solution Mix 




2 X Stain Buffer 300 1 X 
50 mg/mL BSA 24  2 mg/mL 
10 mg/mL Goat IgG stock 6 0.1 mg/mL 
0.5 mg/mL biotinylated 
antibody 
3.6 3 µg/mL 
Mol. Bio water 266.4   
Total  600  
The solution was mixed well and 600 µL was used for the 2nd staining. 
 
The washing and staining of the probe array was performed on the GeneChip Fluidics 
Station 450, according to the manufacturer’s instructions.  
Scanning 
The probe array was scanned after the wash protocols were completed. Scanning was 
performed on the GeneChip Scanner 3000, using the GeneChip® Operating Software 
(GCOS). 
Note: the protocol used in the U133A microarray experiment was identical to the 
proceduce above, except that labeled rRNA was used for hybridisation. 
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18. Others 
Crystal violet staining 
Crystal violet staining was performed as a simple method for documenting attached 
cells. Crystal violet has a known propensity for cell nuclei.(Kueng et al 1989) Cells 
were washed 24 hours after UVB with PBS and stained with 1% crystal violet for 30 
minutes, followed by further washing with PBS. 
Documentation of nuclear morphology 
For the purpose of nuclear size and shape, randomly obtained images stained with 
propidium iodide at 400X magnification was evaluated. The greatest linear dimension 
(L) was measured, as well as the longest width perpendicular to this measurement 
(w). The ‘area’ of each cell was calculated as πX(L/2)X(w/2) and the ‘roundness 
index’ as w/L, where an index of 1 would indicate perfect roundness. A minimum of 
200 randomly selected cells for each experimental condition were measured by a 
single observer. Nuclear images were digitally magnified by a standardized extent to 
facilitate measurements in Adobe Photoshop.   
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Appendix B: Antibodies 
 





beta-actin A5441 Sigma, St Louis, MO Mouse 1:500  
Involucrin Ab-1, clone SY5 Labvision, Frement,CA Mouse 1:200 1:100 
SPRR2 APO-25N-001 Alexis Biochemical's, San Diego, CA Rabbit 1:500 1:100 
SPRR1A ab18580 Abcam Inc, Cambridge, MA Rabbit 1:500 1:50 
Filaggrin BT-576 Biomedical technologies inc, Stoughton,MA Mouse 1:100 1:50 
TGM-1 BT-621 Biomedical technologies inc, Stoughton,MA Mouse 1:500 1:50 
TGM-2 ab421 Abcam Inc, Cambridge, MA Rabbit 1:500 1:50 
TGM-2 ab21258 Abcam Inc, Cambridge, MA Mouse 1:500  
IKB-a 4812 Cell signaling technology, Danvers, MA Rabbit 1:1000 1:50 
p65 3034 Cell signaling technology, Danvers, MA Rabbit 1:1000 1:50 
p65 MAB3026 Chemicon Mouse  1:50 
TNFRSF1A MAB225 clone 16803 RandD systems, Minneapolis, MN Mouse 1:1000 1:10 
JNK sc-571 Santa Cruz Biotech Inc, Santa Cruz, CA Rabbit 1:500  
pJNK sc-6254 Santa Cruz Biotech Inc, Santa Cruz, CA Mouse 1:100  
occludin 
33-1500 clone OC-
3F10 Invitrogen, Carlsbad, CA Mouse  1:50 
claudin 51-9000 clone JAY.8 Invitrogen, Carlsbad, CA Rabbit  1:50 





Appendix C: PCR primers 
 
CE precursor NCBI no Primer sequence Expected product 
size 
SPRR1A NM 005987 F: tggccactggatactgaaca 
R: cccaaatccatcctcaaatg 
230 
SPRR1B NM 003125 F: cattctgtctcccccaaaaa 
R: atgggggtataagggagctg 
172 
SPRR2A NM 005988 F: tatttggctcacctcgttcc 
R: ccaggacttcctttgctcag 
187 
SPRR2B NM 006945 F: taattggctcacctcgttcc 
R: gagctgctgctctttctgct 
229 
SPRR3 BC017802 F: ttccacaacctggaaacaca 
R: ttcagggaccttggtgtagc 
200 
SPRR4 NM 173080 F: caagtgaagcagccttgtca 
R: atctggtagccaggatggtg 
222 















Filaggrin AF043380 F: gctctaggcactcagcatcc 
R: gagccgtctcctgattgttc 
235 
Involucrin NM_005547 F: ggactgcctgagcaagaatgtg 
R: taagctgctgctctgggttt   
121 
Loricrin NM000427 F: gtgggagcgtcaagtactcc 
R: tagagacgcctccgtagctc 
243 
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